CINXE.COM

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#"> <head> <meta charset="utf-8" /> <script async src="https://www.googletagmanager.com/gtag/js?id=G-273DTKB5QW"></script> <meta name="description" content="A list of CVM guidances by number and a list of cross-cutting guidances." /> <meta name="dcterms.title" content="Guidance by Number" /> <meta name="dcterms.creator" content="Center for Veterinary Medicine" /> <meta name="dcterms.description" content="A list of CVM guidances by number and a list of cross-cutting guidances." /> <meta name="dcterms.publisher" content="FDA" /> <meta name="dcterms.type" content="Article" /> <meta name="dcterms.source" content="FDA" /> <meta name="dcterms.audience" content="Media" /> <meta property="og:site_name" content="U.S. Food and Drug Administration" /> <meta property="og:type" content="Article" /> <meta property="og:url" content="https://www.fda.gov/animal-veterinary/guidance-industry/guidance-number" /> <meta property="og:title" content="Guidance by Number" /> <meta property="og:description" content="A list of CVM guidances by number and a list of cross-cutting guidances." /> <meta property="og:updated_time" content="Mon, 01/06/2025 - 00:00" /> <meta property="article:publisher" content="FDA" /> <meta property="article:published_time" content="Mon, 01/06/2025 - 08:56" /> <meta property="article:modified_time" content="Mon, 01/06/2025 - 00:00" /> <meta name="google-site-verification" content="tWxlDhm4ANdksJZPj7TBmHgNoMqZCnecPp0Aa2vC9XA" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:site" content="@US_FDA" /> <meta property="twitter:description" content="A list of CVM guidances by number and a list of cross-cutting guidances." /> <meta name="twitter:title" content="Guidance by Number" /> <meta name="twitter:creator" content="@US_FDA" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <script type="application/ld+json">{ "@context": "https://schema.org", "@graph": [ { "@type": "Article", "headline": "Guidance by Number", "name": "Guidance by Number", "description": "A list of CVM guidances by number and a list of cross-cutting guidances.", "datePublished": "Mon, 01/06/2025 - 08:56", "dateModified": "Mon, 01/06/2025 - 00:00", "author": { "@type": "Organization", "name": "Center for Veterinary Medicine" }, "publisher": { "@type": "Organization", "name": "FDA" } } ] }</script> <meta property="og:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" /> <meta name="twitter:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" /> <link rel="icon" href="/themes/custom/preview/favicon.ico" type="image/vnd.microsoft.icon" /> <link rel="alternate" hreflang="en" href="https://www.fda.gov/animal-veterinary/guidance-industry/guidance-number" /> <link rel="canonical" href="https://www.fda.gov/animal-veterinary/guidance-industry/guidance-number" /> <link rel="shortlink" href="https://www.fda.gov/node/354162" /> <script src="/files/google_tag/production/google_tag.script.js?spd7fh" defer></script> <title>Guidance by Number | FDA</title> <link rel="stylesheet" media="all" href="/files/css/css_1reGTN8IJomDe9NNXuGLDghsOFcqPHURMZ3XKurXneU.css?delta=0&language=en&theme=preview&include=eJxlj1GOwjAMRC8UyP6sxG0i1zEhIslEsRdUTg8FUSr2xxqPpZlnPkvMhhFyi9JsKuCz32h3RDO6iqKK3-i9S0AqEqhRmS2z-m_D6awm1U-k4vqQS5arTwUTlZ3aXHJL_2weuZu6CTC1Qd13dFxkuGOkwG9WaSdqLPUBqZ6YMWJGC4a0AOgJwxhR3BKt_jn3FfGvyCsHtZe8JLxu4ffnsDEfL8MaTNSvagXlQbdZ0oc8Un92vfe1fbeC3QF5KozJ" /> <link rel="stylesheet" media="all" href="/files/css/css_xLeUZALg1CD0YmiSIzZnqkwKfNF_g3TkAjkxBt_uccA.css?delta=1&language=en&theme=preview&include=eJxlj1GOwjAMRC8UyP6sxG0i1zEhIslEsRdUTg8FUSr2xxqPpZlnPkvMhhFyi9JsKuCz32h3RDO6iqKK3-i9S0AqEqhRmS2z-m_D6awm1U-k4vqQS5arTwUTlZ3aXHJL_2weuZu6CTC1Qd13dFxkuGOkwG9WaSdqLPUBqZ6YMWJGC4a0AOgJwxhR3BKt_jn3FfGvyCsHtZe8JLxu4ffnsDEfL8MaTNSvagXlQbdZ0oc8Un92vfe1fbeC3QF5KozJ" /> <script src="https://script.crazyegg.com/pages/scripts/0024/3700.js" async></script> <script src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&subagency=FDA&sdor=fda.gov&dclink=true" language="javascript" id="_fed_an_ua_tag"></script> <script>window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag("js", new Date());gtag("set", "developer_id.dMDhkMT", true);gtag("config", "G-273DTKB5QW", {"groups":"default","page_placeholder":"PLACEHOLDER_page_location","allow_ad_personalization_signals":false});</script> </head> <body class="role-anonymous path-node page-node-type-article has-glyphicons"> <div id="quicklinks" class="sr-only"> <ul> <li><a href="#main-content" class="sr-only sr-only-focusable" tabindex="1">Skip to main content</a></li> <li><a href="#search-form" class="sr-only sr-only-focusable" tabindex="1">Skip to FDA Search</a></li> <li><a href="#section-nav" class="sr-only sr-only-focusable" tabindex="1">Skip to in this section menu</a></li> <li><a href="#footer-heading" class="sr-only sr-only-focusable" tabindex="1">Skip to footer links</a></li> </ul> </div> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M95XGZW" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <div class="main-container container-fluid"> <div class="row"> <header class="lcds-header container-fluid" role="heading" aria-level="1"> <div class="row us-masthead"> <div class="usa-banner col-xs-12"> <img class="usa-banner__us-flag" src="/themes/custom/preview/assets/images/US_Flag.png" alt="U.S. flag" /> <span>An official website of the United States government</span> <a id="USMenuButton" class="collapsed" data-toggle="collapse" data-target="#USABannerMenu" aria-controls="USABannerMenu">Here’s how you know <span class="toggle-indicator"> </span></a> <div class="col-xs-12 collapse usa-banner__menu" id="USABannerMenu" aria-labelledby="USMenuButton"> <div id="gov-banner" class="row usa-banner-content usa-grid usa-accordion-content" aria-hidden="true"> <div class="col-xs-12 col-sm-6 col-md-3"> <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-dot-gov.svg" alt="Dot gov" style="width:3em;"> <div class="usa-media_block-body"> <p><strong>The .gov means it’s official.</strong><br>Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.</p> </div> </div> <div class="col-xs-12 col-sm-6 col-md-3"> <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-https.svg" alt="SSL" style="width:3em;"> <div class="usa-media_block-body"> <p><strong>The site is secure.</strong><br> The <strong>https://</strong> ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.</p> </div> </div> </div> </div> </div> </div> <div class="alert alert-warning margin-left-neg-2 margin-right-neg-2 margin-top-3 margin-bottom-1"> <p>On Oct. 1, 2024, the FDA began implementing a <a href="/about-fda/fda-organization/fda-modernization-efforts-establishing-unified-human-foods-program-new-model-field-operations-and" title="FDA Modernization Efforts for Establishing a Unified Human Foods Program, New Model for Field Operations and More">reorganization</a> impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.</p> </div> <div class="row fda-masthead"> <div class="col-xs-4 col-md-8"> <a href="/" title="FDA Homepage"> <h1 class="fda-masthead__fda-logo">U.S. Food and Drug Administration</h1> </a> </div> <div class="col-xs-8 col-md-4"> <ul class='fda-masthead__item-list'> <li><a title="" id="btn-search" class="btn btn-default btn-sm fda-masthead__btn-search"> <span class="fa fa-search" aria-hidden="true"> </span> <span class="fda-masthead__btn-label">Search</span> </a></li> <li><a id="menu-btn" class="btn btn-default btn-sm fda-masthead__btn-menu collapsed" href="#primary-nav" data-toggle="collapse" aria-expanded="true"> <span class="fa fa-bars" aria-hidden="true"> </span> <span class='fda-masthead__btn-label'>Menu</span> </a></li> </ul> </div> <form class="fda-masthead__search sr-only" role="search" action="/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8" > <div class="search-popover" id="search-popover"> <div class="input-group pull-right" id="search-group"> <label class="sr-only" for="search-query">Search FDA</label> <input class="form-control search-input" id="search-query" name="s" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA" type="text" /> <span class="input-group-btn" id="input-group-btn"> <button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button> </span> </div> </div> </form> </div> <nav id="primary-nav" class="lcds-primary-nav row collapse"> <div class="col-md-5 col-lg-4"> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Featured</h2> <ul class="lcds-primary-nav__list lcds-primary-nav__list--featured"> <li class="lcds-primary-nav__list-item"><a href="https://www.safetyreporting.hhs.gov/smarthub#/" title="Report a Problem with an FDA Regulated Product">Report a Product Problem</a></li> <li class="lcds-primary-nav__list-item"><a href="/about-fda/contact-fda">Contact FDA</a></li> <li class="lcds-primary-nav__list-item"><a href="/regulatory-information/search-fda-guidance-documents">FDA Guidance Documents</a></li> <li class="lcds-primary-nav__list-item"><a href="/safety/recalls-market-withdrawals-safety-alerts">Recalls, Market Withdrawals and Safety Alerts</a></li> <li class="lcds-primary-nav__list-item"><a href="/news-events/newsroom/press-announcements">Press Announcements</a></li> <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a></li> <li class="lcds-primary-nav__list-item"><a href="/advisory-committees">Advisory Committees</a></li> <li class="lcds-primary-nav__list-item"><a href="/fda-en-espanol">En Espa&#241ol</a></li> </ul> </section> </div> <div class="col-md-7 col-lg-8"> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Products</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/food">Food</a></li> <li class="lcds-primary-nav__list-item"><a href="/drugs">Drugs</a></li> <li class="lcds-primary-nav__list-item"><a href="/medical-devices">Medical Devices</a></li> <li class="lcds-primary-nav__list-item"><a href="/radiation-emitting-products">Radiation-Emitting Products</a></li> <li class="lcds-primary-nav__list-item"><a href="/vaccines-blood-biologics">Vaccines, Blood, and Biologics</a></li> <li class="lcds-primary-nav__list-item"><a href="/animal-veterinary">Animal and Veterinary</a></li> <li class="lcds-primary-nav__list-item"><a href="/cosmetics">Cosmetics</a></li> <li class="lcds-primary-nav__list-item"><a href="/tobacco-products">Tobacco Products</a></li> </ul> </section> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Topics</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/about-fda">About FDA</a></li> <li class="lcds-primary-nav__list-item"><a href="/combination-products">Combination Products</a></li> <li class="lcds-primary-nav__list-item"><a href="/regulatory-information">Regulatory Information</a></li> <li class="lcds-primary-nav__list-item"><a href="/safety">Safety</a></li> <li class="lcds-primary-nav__list-item"><a href="/emergency-preparedness-and-response">Emergency Preparedness</a></li> <li class="lcds-primary-nav__list-item"><a href="/international-programs">International Programs</a></li> <li class="lcds-primary-nav__list-item"><a href="/news-events">News and Events</a></li> <li class="lcds-primary-nav__list-item"><a href="/training-and-continuing-education">Training and Continuing Education</a></li> <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections and Compliance</a></li> <li class="lcds-primary-nav__list-item"><a href="/science-research">Science and Research</a></li> </ul> </section> <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered"> <h2 class="lcds-primary-nav__group-heading">Information For</h2> <ul class="lcds-primary-nav__list"> <li class="lcds-primary-nav__list-item"><a href="/consumers">Consumers</a></li> <li class="lcds-primary-nav__list-item"><a href="/patients">Patients</a></li> <li class="lcds-primary-nav__list-item"><a href="/industry">Industry</a></li> <li class="lcds-primary-nav__list-item"><a href="/health-professionals">Health Professionals</a></li> <li class="lcds-primary-nav__list-item"><a href="/federal-state-local-tribal-and-territorial-officials">Federal, State and Local Officials</a></li> </ul> </section> </div> </nav> </header> <div class="col-xs-12"> <div data-drupal-messages-fallback class="hidden"></div> </div> <section id="block-entityviewcontent" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <a class="lcds-button--expandable collapsed hidden-md hidden-lg" data-toggle="collapse" href="#section-nav" >In this section<span class="visible-sm-inline-block">: Guidance for Industry </span> </a> <nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav hidden-md hidden-lg collapse"> <ul class="lcds-section-nav__list"> <li> <a href="/animal-veterinary/guidance-regulations/guidance-industry" title="Guidance for Industry" class="lcds-section-nav__section-link lcds-section-nav__link lcds-section-nav__parent-link visible-xs-block visible-sm-block"> Guidance for Industry </a> <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_5 js-view-dom-id-b81b0d3353ecbf68f5ff76e21177682d2d5d89699653431e963019b0f7f0773d"> <div> <ul class="lcds-section-nav__section-link__active lcds-section-nav__list"> <li><a href="/animal-veterinary/guidance-industry/guidance-number" class="lcds-section-nav__link">Guidance by Number</a></li> <li><a href="/animal-veterinary/guidance-industry/guidances-under-development" class="lcds-section-nav__link">Guidances Under Development</a></li> <li><a href="/animal-veterinary/guidance-industry/newly-added-guidances" class="lcds-section-nav__link">Newly Added Guidances</a></li> <li><a href="/animal-veterinary/guidance-industry/withdrawnreplaced-guidances" class="lcds-section-nav__link">Withdrawn/Replaced Guidances</a></li> </ul> </div> </div> </div> <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_2 js-view-dom-id-8aee3132a038fb5623e8b833647ad06c68a292b9789767e70671f5f7afa59249"> </div> </div> </li> </ul> </nav> </section> <section id="block-entityviewcontent-15" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <ol class="lcds-breadcrumb visible-md visible-lg"> <li > <a href="/">Home</a> </li> <li > <a href="/animal-veterinary">Animal & Veterinary</a> </li> <li > <a href="/animal-veterinary/guidance-regulations">Guidance & Regulations</a> </li> <li > <a href="/animal-veterinary/guidance-regulations/guidance-industry">Guidance for Industry</a> </li> <li > <a class="current-link">Guidance by Number</a> </li> </ol> <ol class="lcds-breadcrumb visible-sm visible-xs"> <li> <a href="/animal-veterinary/guidance-regulations/guidance-industry" title="Guidance for Industry"> Guidance for Industry </a> </li> </ol> </section> <main> <article id="main-content" class="article main-content container-fluid" role="article"> <header class="row content-header" role="heading" aria-level="1"> <section id="block-entityviewcontent-2" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="col-sm-12 col-md-8 col-md-offset-2"> <h1 class="content-title text-center">Guidance by Number</h1> <div class="lcds-toolbar lcds-toolbar--social"> <ul class="lcds-share lcds-share--default"> <li class="lcds-share__item"> <a href="https://www.facebook.com/sharer/sharer.php?u=https://www.fda.gov%2Fanimal-veterinary%2Fguidance-industry%2Fguidance-number" class="lcds-share__btn lcds-share--default__btn-facebook js-share" id="fb-share" target="_blank"><span class="fa icon-facebook" aria-hidden="true"></span>Share</a> </li> <li class="lcds-share__item"> <a href="https://x.com/intent/tweet/?text=Guidance%20by%20Number&url=https://www.fda.gov%2Fanimal-veterinary%2Fguidance-industry%2Fguidance-number" target="_blank" class="lcds-share__btn lcds-share--default__btn-x-twitter js-share" id="twitter-share"> <svg class="icon-svg-inline" aria-hidden="true"> <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter"> </svg> Post </a> </li> <li class="lcds-share__item hidden-xs"> <a href="https://www.linkedin.com/shareArticle?mini=true&url=https://www.fda.gov%2Fanimal-veterinary%2Fguidance-industry%2Fguidance-number&title=Guidance%20by%20Number&source=FDA" class="lcds-share__btn lcds-share--default__btn-linkedin js-share" id="linkedin-share" target="_blank"><span class="fa icon-linkedin" aria-hidden="true"></span>Linkedin</a> </li> <li class="lcds-share__item"> <a href="mailto:?subject=Guidance%20by%20Number&body=https://www.fda.gov%2Fanimal-veterinary%2Fguidance-industry%2Fguidance-number" class="lcds-share__btn lcds-share--default__btn-mail"><span class="fa icon-envelope" aria-hidden="true"></span>Email</a> </li> <li class=" lcds-share__item hidden-xs"> <a href="javascript:window.print();" title="Print this page" class="lcds-share__btn lcds-share--default__btn-print"><span class="fa icon-print" aria-hidden="true"></span>Print</a> </li> </ul> <div class="form-group"> </div> </div> </div> </section> </header> <div class="col-md-8 col-md-push-2" role="main"> <p><a href="#CVM">CVM Guidances</a><br><a href="#cross">Cross-Cutting Guidances</a></p><h2 id="CVM">Guidance by Number</h2><ul><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-3-general-principles-evaluating-human-food-safety-new-animal-drugs-used-food-producing" data-entity-type="node" data-entity-uuid="49ea54de-a29e-492c-8d8a-73a45a277546" data-entity-substitution="canonical" title="CVM GFI #3 General Principles for Evaluating the Human Food Safety of New Animal Drugs Used In Food-Producing Animals">CVM GFI #3 General Principles for Evaluating the Human Food Safety of New Animal Drugs Used In Food-Producing Animals</a><br>May 10, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-5-drug-stability-guidelines" data-entity-type="node" data-entity-uuid="b894930f-326f-4123-bbb1-a2952062bf9b" data-entity-substitution="canonical" title="CVM GFI #5 Drug Stability Guidelines">CVM GFI #5 Drug Stability Guidelines</a><br>December 9, 2008</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-13-evaluation-effectiveness-new-animal-drugs-use-free-choice-feeds-medicated-block" data-entity-type="node" data-entity-uuid="32864e8b-c7c4-4e9d-a64c-4ccb1a61fe6d" data-entity-substitution="canonical" title="CVM GFI #13 Evaluation of Effectiveness of New Animal Drugs for Use in Free-Choice Feeds-Medicated Block">CVM GFI #13 Evaluation of Effectiveness of New Animal Drugs for Use in Free-Choice Feeds-Medicated Block</a><br>January 1, 1985</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-23-medicated-free-choice-feeds-manufacturing-control" data-entity-type="node" data-entity-uuid="3cb66ff2-a6da-4778-86bb-90880a1bb13f" data-entity-substitution="canonical" title="CVM GFI #23 Medicated Free Choice Feeds--Manufacturing Control">CVM GFI #23 Medicated Free Choice Feeds--Manufacturing Control</a><br>July 1, 1985</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-24-drug-combinations-use-animals" data-entity-type="node" data-entity-uuid="8bff3a4f-d2fa-497d-bda7-b213e45ceeb6" data-entity-substitution="canonical" title="CVM GFI #24 Drug Combinations for Use in Animals">CVM GFI #24 Drug Combinations for Use in Animals</a><br>October 1, 1983</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-35-bioequivalence-guidance" data-entity-type="node" data-entity-uuid="475ef328-9c0a-42d2-b543-38eda632b923" data-entity-substitution="canonical" title="CVM GFI #35 Bioequivalence Guidance">CVM GFI #35 Bioequivalence Guidance</a><br>November 8, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-37-evaluation-effectiveness-new-animal-drugs-use-poultry-feed-pigmentation" data-entity-type="node" data-entity-uuid="daf436c7-a8e6-4e6e-88c2-a7d952f4bdc0" data-entity-substitution="canonical" title="CVM GFI #37 Evaluation of Effectiveness of New Animal Drugs for Use in Poultry Feed for Pigmentation">CVM GFI #37 Evaluation of Effectiveness of New Animal Drugs for Use in Poultry Feed for Pigmentation</a><br>March 1, 1984</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-38-guideline-effectiveness-evaluation-topicalotic-animal-drugs" data-entity-type="node" data-entity-uuid="d1ecdd13-ab5f-43d3-8d2e-b28a4901dc31" data-entity-substitution="canonical" title="CVM GFI #38 Guideline for Effectiveness Evaluation of Topical/Otic Animal Drugs">CVM GFI #38 Guideline for Effectiveness Evaluation of Topical/Otic Animal Drugs</a><br>August 21, 1984</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-45-guideline-uniform-labeling-drugs-dairy-and-beef-cattle" data-entity-type="node" data-entity-uuid="7420a8b8-0c7e-49e0-990c-32c223cae21c" data-entity-substitution="canonical" title="CVM GFI #45 Guideline for Uniform Labeling of Drugs for Dairy and Beef Cattle">CVM GFI #45 Guideline for Uniform Labeling of Drugs for Dairy and Beef Cattle</a><br>August 1, 1993</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-49-evaluating-target-animal-safety-and-effectiveness-antibacterial-new-animal-drugs-bovine" data-entity-type="node" data-entity-uuid="da215bcb-a3e5-40d9-9e67-48a011bf042e" data-entity-substitution="canonical" title="CVM GFI #49 Evaluating Target Animal Safety and Effectiveness of Antibacterial New Animal Drugs for Bovine Mastitis">CVM GFI #49 Evaluating Target Animal Safety and Effectiveness of Antibacterial New Animal Drugs for Bovine Mastitis</a><br>December 4, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-53-evaluation-utility-food-additives-diet-fed-aquatic-animals" data-entity-type="node" data-entity-uuid="cd190847-0713-4e36-a9f5-f18e8342e146" data-entity-substitution="canonical" title="CVM GFI #53 Evaluation of the Utility of Food Additives in Diet Fed to Aquatic Animals">CVM GFI #53 Evaluation of the Utility of Food Additives in Diet Fed to Aquatic Animals</a><br>May 1, 1994</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-55-supportive-data-cat-food-labels-bearing-reduces-urinary-ph-claims-protocol-development" data-entity-type="node" data-entity-uuid="82466e1b-0f5c-432c-afcc-476533834bfb" data-entity-substitution="canonical" title="CVM GFI #55 Supportive Data for Cat Food Labels Bearing "Reduces Urinary pH Claims: Protocol Development">CVM GFI #55 Supportive Data for Cat Food Labels Bearing "Reduces Urinary pH Claims": Protocol Development</a><br>June 1, 1994</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-56-protocol-development-guideline-clinical-effectiveness-and-target-animal-safety-trials" data-entity-type="node" data-entity-uuid="f75b2f1d-a2d6-4bf2-8012-eddd538b49a7" data-entity-substitution="canonical" title="CVM GFI #56 Protocol Development Guideline for Clinical Effectiveness and Target Animal Safety Trials">CVM GFI #56 Protocol Development Guideline for Clinical Effectiveness and Target Animal Safety Trials</a><br>July 10, 2001</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-57-preparation-and-submission-veterinary-master-files" data-entity-type="node" data-entity-uuid="605bdaed-1f07-4271-bbdd-02a9fd051350" data-entity-substitution="canonical" title="CVM GFI #57 Preparation and Submission of Veterinary Master Files">CVM GFI #57 Preparation and Submission of Veterinary Master Files</a><br>January 1, 1995</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-61-special-considerations-incentives-and-programs-support-approval-new-animal-drugs-minor" data-entity-type="node" data-entity-uuid="61795f95-5de3-4295-9ffe-665521580071" data-entity-substitution="canonical" title="CVM GFI #61 Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species ">CVM GFI #61 Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species</a><br>December 22, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/consumer-directed-broadcast-advertisements" data-entity-type="node" data-entity-uuid="897fbb81-e30c-41fe-ae4a-88bec2036e11" data-entity-substitution="canonical" title="Consumer-Directed Broadcast Advertisements">CVM GFI #62 Consumer Directed Broadcast Advertisements</a><br>August 1, 1999</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-63-vich-gl1-validation-analytical-procedures-definition-and-terminology" data-entity-type="node" data-entity-uuid="2fa70cf9-f968-4e8e-bf9c-65ef6de3a663" data-entity-substitution="canonical" title="CVM GFI #63 (VICH GL1) Validation of Analytical Procedures: Definition and Terminology">CVM GFI #63 (VICH GL1) Validation of Analytical Procedures: Definition and Terminology</a><br>August 28, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-64-vich-gl2-validation-analytical-procedures-methodology" data-entity-type="node" data-entity-uuid="704fa6c1-ccaf-4d16-b2aa-141c45e8577b" data-entity-substitution="canonical" title="CVM GFI #64 (VICH GL2) Validation of Analytical Procedures: Methodology">CVM GFI #64 (VICH GL2) Validation of Analytical Procedures: Methodology</a><br>August 28, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/industry-supported-scientific-and-educational-activities" data-entity-type="node" data-entity-uuid="e51637b5-3a31-40ab-bdd8-96363b2bf65b" data-entity-substitution="canonical" title="Industry Supported Scientific and Educational Activities">CVM GFI #65 Industry Supported Scientific and Educational Activities</a><br>November 1, 1997</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-67-small-entities-compliance-guide-renderers" data-entity-type="node" data-entity-uuid="8e558669-7fef-4a97-b0dd-f61c929442ef" data-entity-substitution="canonical" title="CVM GFI #67 Small Entities Compliance Guide for Renderers">CVM GFI #67 Small Entities Compliance Guide for Renderers</a><br>February 1, 1998</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-68-small-entities-compliance-guide-protein-blenders-feed-manufacturers-and-distributors" data-entity-type="node" data-entity-uuid="90a87be9-30f2-4e83-ae49-939c34d857fa" data-entity-substitution="canonical" title="CVM GFI #68 Small Entities Compliance Guide for Protein Blenders, Feed Manufacturers, and Distributors">CVM GFI #68 Small Entities Compliance Guide for Protein Blenders, Feed Manufacturers, and Distributors</a><br>February 1, 1998</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-69-small-entities-compliance-guide-feeders-ruminant-animals-farm-feed-mixing-operations" data-entity-type="node" data-entity-uuid="794387b9-fe82-4f70-a0c1-0a6bede9a837" data-entity-substitution="canonical" title="CVM GFI #69 Small Entities Compliance Guide for Feeders of Ruminant Animals with On-Farm Feed Mixing Operations">CVM GFI #69 Small Entities Compliance Guide for Feeders of Ruminant Animals with On-Farm Feed Mixing Operations</a><br>February 1, 1998</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-70-small-entities-compliance-guide-feeders-ruminant-animals-without-farm-feed-mixing" data-entity-type="node" data-entity-uuid="b9b7f341-5b01-45f2-b7c9-a04e56bf94ed" data-entity-substitution="canonical" title="CVM GFI #70 Small Entities Compliance Guide for Feeders of Ruminant Animals Without On-Farm Feed Mixing Operations">CVM GFI #70 Small Entities Compliance Guide for Feeders of Ruminant Animals Without On-Farm Feed Mixing Operations</a><br>July 13, 2009</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-72-gmps-medicated-feed-manufacturers-not-required-register-and-be-licensed-fda" data-entity-type="node" data-entity-uuid="a8f6f4bb-7119-4f7d-ac98-069d7869b693" data-entity-substitution="canonical" title="CVM GFI #72 GMP'S For Medicated Feed Manufacturers Not Required to Register and be Licensed with FDA">CVM GFI #72 GMP'S For Medicated Feed Manufacturers Not Required to Register and be Licensed with FDA</a><br>May 1, 1998</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-73-vich-gl3r-stability-testing-new-veterinary-drug-substances-and-medicinal-products" data-entity-type="node" data-entity-uuid="be563d15-3515-4b99-8d1e-0a0a6faa31c5" data-entity-substitution="canonical" title="CVM GFI #73 (VICH GL3(R)) Stability Testing of New Veterinary Drug Substances and Medicinal Products">CVM GFI #73 (VICH GL3(R)) Stability Testing of New Veterinary Drug Substances and Medicinal Products</a><br>November 21, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-74-vich-gl4-stability-testing-new-veterinary-dosage-forms" data-entity-type="node" data-entity-uuid="d4affb5a-9373-4075-9d35-1cae1dace16b" data-entity-substitution="canonical" title="CVM GFI #74 (VICH GL4 ) Stability Testing of New Veterinary Dosage Forms">CVM GFI #74 (VICH GL4 ) Stability Testing of New Veterinary Dosage Forms</a><br>September 1, 1999</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-75-vich-gl5-stability-testing-photostability-testing-new-veterinary-drug-substances-and" data-entity-type="node" data-entity-uuid="f5501a1f-a38d-4ead-b26b-0e2d9abc2e6a" data-entity-substitution="canonical" title="CVM GFI #75 (VICH GL5) Stability Testing-Photostability Testing of New Veterinary Drug Substances and Medicinal Products">CVM GFI #75 (VICH GL5) Stability Testing-Photostability Testing of New Veterinary Drug Substances and Medicinal Products</a><br>September 1, 1999</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-76-questions-and-answers-bse-feed-regulations" data-entity-type="node" data-entity-uuid="8b417e90-02e0-4e28-b498-57aa3783e145" data-entity-substitution="canonical" title="CVM GFI #76 Questions and Answers BSE Feed Regulations">CVM GFI #76 Questions and Answers BSE Feed Regulations</a><br>July 1, 1998</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-79-dispute-resolution-procedures-science-based-decisions-products-regulated-cvm" data-entity-type="node" data-entity-uuid="bb1c66f0-9db0-4997-a81a-b423f13de667" data-entity-substitution="canonical" title="CVM GFI #79 Dispute Resolution Procedures for Science-Based Decisions on Products Regulated by CVM">CVM GFI #79 Dispute Resolution Procedures for Science-Based Decisions on Products Regulated by CVM</a><br>May 29, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-80-evaluation-utility-anti-salmonella-chemical-food-additives" data-entity-type="node" data-entity-uuid="6ae38fa9-cb4e-48c7-a782-f31c317c10cf" data-entity-substitution="canonical" title="CVM GFI #80 Evaluation the Utility of Anti-Salmonella Chemical Food Additives">CVM GFI #80 Evaluation the Utility of Anti-Salmonella Chemical Food Additives</a><br>November 21, 2002</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-82-development-supplemental-applications-approved-new-animal-drugs" data-entity-type="node" data-entity-uuid="cd1da624-3f25-433a-83a3-2bceba9883a3" data-entity-substitution="canonical" title="CVM GFI #82 Development of Supplemental Applications for Approved New Animal Drugs">CVM GFI #82 Development of Supplemental Applications for Approved New Animal Drugs</a><br>October 28, 2002</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-83-chemistry-manufacturing-and-controls-changes-approved-nadaanada" data-entity-type="node" data-entity-uuid="4acebc1d-a660-4242-8aad-e8fa60f38e39" data-entity-substitution="canonical" title="CVM GFI #83 Chemistry, Manufacturing and Controls Changes to Approved NADA/ANADA">CVM GFI #83 Chemistry, Manufacturing and Controls Changes to Approved NADA/ANADA</a><br>May 30, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-85-vich-gl9-good-clinical-practice" data-entity-type="node" data-entity-uuid="fb5aaacf-ed2e-4e95-a5ab-c8c48d8ad8dc" data-entity-substitution="canonical" title="CVM GFI #85 (VICH GL9) Good Clinical Practice">CVM GFI #85 (VICH GL9) Good Clinical Practice</a><br>May 9, 2001</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-89-vich-gl6-eias-veterinary-medicinal-products-phase-i" data-entity-type="node" data-entity-uuid="d91fa339-bac7-4011-8f38-bcf6a417922e" data-entity-substitution="canonical" title="CVM GFI #89 (VICH GL6) EIAs for Veterinary Medicinal Products - Phase I">CVM GFI #89 (VICH GL6) EIAs for Veterinary Medicinal Products - Phase I</a><br>March 7, 2001</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-90-vich-gl7-effectiveness-anthelmintics-general-recommendations" data-entity-type="node" data-entity-uuid="6da732ac-55e6-4074-9384-675316f6e97c" data-entity-substitution="canonical" title="CVM GFI #90 (VICH GL7) Effectiveness of Anthelmintics: General Recommendations">CVM GFI #90 (VICH GL7) Effectiveness of Anthelmintics: General Recommendations</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-91-vich-gl8-stability-testing-medicated-premixes" data-entity-type="node" data-entity-uuid="af6bd46d-bd9f-433a-8155-4e08453966a5" data-entity-substitution="canonical" title="CVM GFI #91 (VICH GL8) Stability Testing for Medicated Premixes">CVM GFI #91 (VICH GL8) Stability Testing for Medicated Premixes</a><br>March 1, 2000</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-92-vich-gl10r-impurities-new-veterinary-drug-substances" data-entity-type="node" data-entity-uuid="e785e505-d935-4043-ad47-6ba33990a998" data-entity-substitution="canonical" title="CVM GFI #92 (VICH GL10(R)) Impurities In New Veterinary Drug Substances">CVM GFI #92 (VICH GL10(R)) Impurities In New Veterinary Drug Substances</a><br>November 26, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-93-vich-gl11r-impurities-new-veterinary-medicinal-products" data-entity-type="node" data-entity-uuid="6502fbeb-b317-48c0-9adc-817c2c0efe47" data-entity-substitution="canonical" title="CVM GFI #93 (VICH GL11(R)) Impurities in New Veterinary Medicinal Products">CVM GFI #93 (VICH GL11(R)) Impurities in New Veterinary Medicinal Products</a><br>November 21, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-95-vich-gl12-effectiveness-anthelmintics-specific-recommendations-bovines" data-entity-type="node" data-entity-uuid="1af6a5ad-4b4c-43d9-9dd8-d01d74d9fabc" data-entity-substitution="canonical" title="CVM GFI #95 (VICH GL12) Effectiveness of Anthelmintics: Specific Recommendations for Bovines">CVM GFI #95 (VICH GL12) Effectiveness of Anthelmintics: Specific Recommendations for Bovines</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-96-vich-gl13-effectiveness-anthelmintics-specific-recommendations-ovines" data-entity-type="node" data-entity-uuid="bb8722f9-8fd8-4c74-b87b-14c3ef4cc939" data-entity-substitution="canonical" title="CVM GFI #96 (VICH GL13) Effectiveness of Anthelmintics: Specific Recommendations for Ovines">CVM GFI #96 (VICH GL13) Effectiveness of Anthelmintics: Specific Recommendations for Ovines</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-97-vich-gl14-effectiveness-anthelmintics-specific-recommendations-caprines" data-entity-type="node" data-entity-uuid="b6898d68-8a65-40d0-aae6-11174317c2e8" data-entity-substitution="canonical" title="CVM GFI #97 (VICH GL14) Effectiveness of Anthelmintics: Specific Recommendations for Caprines">CVM GFI #97 (VICH GL14) Effectiveness of Anthelmintics: Specific Recommendations for Caprines</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-98-dioxin-anti-caking-agents-animal-feed-and-feed-ingredients" data-entity-type="node" data-entity-uuid="94951d0b-fb79-4aad-ad47-981e16162228" data-entity-substitution="canonical" title="CVM GFI #98 Dioxin In Anti-Caking Agents In Animal Feed And Feed Ingredients">CVM GFI #98 Dioxin In Anti-Caking Agents In Animal Feed And Feed Ingredients</a><br>April 12, 2000</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-99-vich-gl17-testing-new-biotechnologicalbiological-products" data-entity-type="node" data-entity-uuid="43d9a53e-03c7-488a-a122-b2dc7802d89d" data-entity-substitution="canonical" title="CVM GFI #99 (VICH GL17) Testing of New Biotechnological/Biological Products">CVM GFI #99 (VICH GL17) Testing of New Biotechnological/Biological Products</a><br>March 26, 2001</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-100-vich-gl18-r2-impurities-residual-solvents-new-veterinary-medicinal-products-active" data-entity-type="node" data-entity-uuid="f748c9d0-964f-47eb-a470-2e55d412720a" data-entity-substitution="canonical" title="CVM GFI #100 (VICH GL18 (R2)) Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substances and Excipients (Revision 2)">CVM GFI #100 (VICH GL18 (R2)) Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substances and Excipients (Revision 2)</a><br>July 25, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/possible-dioxinpcb-contamination-drug-and-biological-products" data-entity-type="node" data-entity-uuid="1963f351-ebc7-4a04-99be-e4380de181d8" data-entity-substitution="canonical" title="Possible Dioxin/PCB Contamination of Drug and Biological Products">CVM GFI #103 Possible Dioxin/PCB Contamination of Drug and Biological Products</a></li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-104-content-and-format-effectiveness-and-target-animal-safety-technical-sections-and-final" data-entity-type="node" data-entity-uuid="bcc219b4-c54c-46e3-9ddc-b9a45a0a49a9" data-entity-substitution="canonical" title="CVM GFI #104 Content and Format of Effectiveness and Target Animal Safety Technical Sections and Final Study Reports For Submission">CVM GFI #104 Content and Format of Effectiveness and Target Animal Safety Technical Sections and Final Study Reports For Submission</a><br>July 10, 2001</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-106-use-published-literature-support-new-animal-drug-approvals" data-entity-type="node" data-entity-uuid="1234af0f-03c3-4fda-8294-b0341a438d79" data-entity-substitution="canonical" title="CVM GFI #106 The Use of Published Literature in Support of New Animal Drug Approvals">CVM GFI #106 The Use of Published Literature in Support of New Animal Drug Approvals</a><br>March 16, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-108-registering-cvms-electronic-submission-system" data-entity-type="node" data-entity-uuid="7b19cae2-72e9-410f-b7e3-0e1937e10668" data-entity-substitution="canonical" title="CVM GFI #108 Registering with CVM’s Electronic Submission System">CVM GFI #108 Registering with CVM’s Electronic Submission System</a><br>April 26, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-109-vich-gl15-effectiveness-anthelmintics-specific-recommendations-equines" data-entity-type="node" data-entity-uuid="f0ac104c-777f-4cf5-870d-da9f5a4ec04d" data-entity-substitution="canonical" title="CVM GFI #109 (VICH GL15) Effectiveness of Anthelmintics: Specific Recommendations for Equines">CVM GFI #109 (VICH GL15) Effectiveness of Anthelmintics: Specific Recommendations for Equines</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-110-vich-gl16-effectiveness-anthelmintics-specific-recommendations-porcines" data-entity-type="node" data-entity-uuid="b528b9c5-5da5-487a-97a6-c647734fdc74" data-entity-substitution="canonical" title="CVM GFI #110 (VICH GL16) Effectiveness of Anthelmintics: Specific Recommendations for Porcines">CVM GFI #110 (VICH GL16) Effectiveness of Anthelmintics: Specific Recommendations for Porcines</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-111-vich-gl19-effectiveness-anthelmintics-specific-recommendations-canines" data-entity-type="node" data-entity-uuid="664da6b6-a351-4862-be1d-6ce5fb1c4707" data-entity-substitution="canonical" title="CVM GFI #111 (VICH GL19) Effectiveness of Anthelmintics: Specific Recommendations for Canines">CVM GFI #111 (VICH GL19) Effectiveness of Anthelmintics: Specific Recommendations for Canines</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-fumonisin-levels-human-foods-and-animal-feeds" data-entity-type="node" data-entity-uuid="dfe4e414-2fb3-4f50-ba9b-c008a3e43083" data-entity-substitution="canonical" title="Guidance for Industry: Fumonisin Levels in Human Foods and Animal Feeds">CVM GFI #112 Fumonisin Levels in Human Foods and Animal Feeds; Final Guidance</a><br>November 9, 2001</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-113-vich-gl20-effectiveness-anthelmintics-specific-recommendations-felines" data-entity-type="node" data-entity-uuid="934b07d6-cc2f-4998-aacf-e55315d0eecf" data-entity-substitution="canonical" title="CVM GFI #113 (VICH GL20) Effectiveness of Anthelmintics: Specific Recommendations for Felines">CVM GFI #113 (VICH GL20) Effectiveness of Anthelmintics: Specific Recommendations for Felines</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-114-vich-gl21-effectiveness-anthelmintics-specific-recommendations-chickens-gallus-gallus" data-entity-type="node" data-entity-uuid="cff35050-b04f-41ef-b0c0-e4c33d491b36" data-entity-substitution="canonical" title="CVM GFI #114 (VICH GL21) Effectiveness of Anthelmintics: Specific Recommendations for Chickens Gallus gallus">CVM GFI #114 (VICH GL21) Effectiveness of Anthelmintics: Specific Recommendations for Chickens Gallus gallus</a><br>August 12, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-115-vich-gl22-studies-evaluate-safety-residues-veterinary-drugs-human-food-reproduction" data-entity-type="node" data-entity-uuid="d9f8ebcd-fe46-40a1-9bda-190118896516" data-entity-substitution="canonical" title="CVM GFI #115 (VICH GL22) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Reproduction Toxicity Testing (Revision 1)">CVM GFI #115 (VICH GL22) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Reproduction Toxicity Testing (Revision 1)</a><br>May 23, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-116-vich-gl23-r2-studies-evaluate-safety-residues-veterinary-drugs-human-food-genotoxicity" data-entity-type="node" data-entity-uuid="2bdfd06c-4d6f-4037-9ac6-6d377e4295a0" data-entity-substitution="canonical" title="CVM GFI #116 (VICH GL23 (R2)) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Genotoxicity Testing (Revision 2)">CVM GFI #116 (VICH GL23 (R2)) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Genotoxicity Testing (Revision 2)</a><br>September 30, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-117-vich-gl24-management-adverse-event-reports-aers" data-entity-type="node" data-entity-uuid="53b819d3-6f03-4ea9-b574-9fd62b73e738" data-entity-substitution="canonical" title="CVM GFI #117 (VICH GL24) Management of Adverse Event Reports (AER's)">CVM GFI #117 (VICH GL24) Management of Adverse Event Reports (AER's)</a><br>May 1, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-118-mass-spectrometry-confirmation-identity-animal-drug-residues" data-entity-type="node" data-entity-uuid="974ff750-ec91-4f6a-824d-aa3acb1fabce" data-entity-substitution="canonical" title="CVM GFI #118 Mass Spectrometry for Confirmation of Identity of Animal Drug Residues">CVM GFI #118 Mass Spectrometry for Confirmation of Identity of Animal Drug Residues</a><br>May 1, 2003 </li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-119-how-cvm-intends-handle-deficient-submissions-filed-during-investigation-new-animal-drug" data-entity-type="node" data-entity-uuid="313f94b1-2317-42e6-8392-1eeaf5af6421" data-entity-substitution="canonical" title="CVM GFI #119 How CVM Intends to Handle Deficient Submissions Filed During the Investigation of a New Animal Drug">CVM GFI #119 How CVM Intends to Handle Deficient Submissions Filed During the Investigation of a New Animal Drug</a><br>August 29, 2002</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-120-veterinary-feed-directive-regulation-questions-and-answers" data-entity-type="node" data-entity-uuid="7f098e2d-1553-4108-b6ef-359e419821c8" data-entity-substitution="canonical" title="CVM GFI #120 Veterinary Feed Directive Regulation Questions and Answers">CVM GFI #120 Veterinary Feed Directive Regulation Questions and Answers</a><br>April 29, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-122-manufacture-and-labeling-raw-meat-foods-companion-and-captive-noncompanion-carnivores" data-entity-type="node" data-entity-uuid="a8b8da4f-a3e9-445b-8962-acb2dbad708c" data-entity-substitution="canonical" title="CVM GFI #122 Manufacture and Labeling of Raw Meat Foods for Companion and Captive Noncompanion Carnivores and Omnivores">CVM GFI #122 Manufacture and Labeling of Raw Meat Foods for Companion and Captive Noncompanion Carnivores and Omnivores</a><br>November 9, 2004</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-123-development-data-supporting-approval-nsaids-use-animals" data-entity-type="node" data-entity-uuid="5163b70b-56c2-4580-a8eb-eb552ec5493a" data-entity-substitution="canonical" title="CVM GFI #123 Development of Data Supporting Approval of NSAIDS for Use in Animals">CVM GFI #123 Development of Data Supporting Approval of NSAIDS for Use in Animals</a><br>January 5, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-126-bacpac-i-intermediates-drug-substance-synthesis-bulk-actives-postapproval-changes" data-entity-type="node" data-entity-uuid="fa2ee039-bc3f-468c-81d0-e460fcaf1192" data-entity-substitution="canonical" title="CVM GFI #126 BACPAC I-Intermediates in Drug Substance Synthesis Bulk Actives Postapproval Changes: Chemistry, Manufacturing, and Controls Documentation">CVM GFI #126 BACPAC I-Intermediates in Drug Substance Synthesis Bulk Actives Postapproval Changes: Chemistry, Manufacturing, and Controls Documentation</a><br>June 1, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-132-administrative-applications-and-phased-review-process" data-entity-type="node" data-entity-uuid="086ee1d6-da89-4348-8e93-90abcedd6f0f" data-entity-substitution="canonical" title="CVM GFI #132 Administrative Applications and the Phased Review Process">CVM GFI #132 Administrative Applications and the Phased Review Process</a><br>May 23, 2018</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-135-validation-analytical-procedures-type-c-medicated-feeds" data-entity-type="node" data-entity-uuid="88e735c5-f9dd-48ff-a0f2-72d3249cd9a2" data-entity-substitution="canonical" title="CVM GFI #135 Validation of Analytical Procedures for Type C Medicated Feeds">CVM GFI #135 Validation of Analytical Procedures for Type C Medicated Feeds</a><br>November 7, 2005</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-136-protocols-conduct-method-transfer-studies-type-c-medicated-feed-assay-methods" data-entity-type="node" data-entity-uuid="d465ed39-a50e-4779-8f74-0f4604b301e7" data-entity-substitution="canonical" title="CVM GFI #136 Protocols for the Conduct of Method Transfer Studies for Type C Medicated Feed Assay Methods">CVM GFI #136 Protocols for the Conduct of Method Transfer Studies for Type C Medicated Feed Assay Methods</a><br>April 26,  2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-137-analytical-methods-description-type-c-medicated-feeds" data-entity-type="node" data-entity-uuid="d48889f7-b759-4e99-97c8-724ab02aa1a3" data-entity-substitution="canonical" title="CVM GFI #137 Analytical Methods Description for Type C Medicated Feeds">CVM GFI #137 Analytical Methods Description for Type C Medicated Feeds</a><br>May 8, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-141-vich-gl28-studies-evaluate-safety-residues-veterinary-drugs-human-food-carcinogenicity" data-entity-type="node" data-entity-uuid="28046bdf-b6fc-4de0-a45d-caa3bf88f0a8" data-entity-substitution="canonical" title="CVM GFI #141 (VICH GL28) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Carcinogenicity Testing">CVM GFI #141 (VICH GL28) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Carcinogenicity Testing</a><br>July 27, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-142-vich-gl29-pharmacovigilance-veterinary-medicinal-products-management-periodic-summary" data-entity-type="node" data-entity-uuid="6ea0c825-f796-44a6-8d91-52669a029bef" data-entity-substitution="canonical" title="CVM GFI #142 (VICH GL29) Pharmacovigilance of Veterinary Medicinal Products: Management of Periodic Summary Update Reports (PSUs)">CVM GFI #142 (VICH GL29) Pharmacovigilance of Veterinary Medicinal Products: Management of Periodic Summary Update Reports (PSUs)</a><br>December 6, 2001</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-143-vich-gl30-pharmacovigilance-veterinary-medicinal-products-controlled-list-terms" data-entity-type="node" data-entity-uuid="276d4411-b40c-4116-9c71-0f6819f761d7" data-entity-substitution="canonical" title="CVM GFI #143 (VICH GL30) Pharmacovigilance of Veterinary Medicinal Products: Controlled List of Terms">CVM GFI #143 (VICH GL30) Pharmacovigilance of Veterinary Medicinal Products: Controlled List of Terms</a><br>October 9, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-144-vich-gl27-pre-approval-information-registration-new-veterinary-medicinal-products-food" data-entity-type="node" data-entity-uuid="39836de8-d9e9-4b0e-8474-d82a43c2b7e2" data-entity-substitution="canonical" title="CVM GFI #144 (VICH GL27) Pre-Approval Information for Registration of New Veterinary Medicinal Products for Food-Producing Animals with Respect to Antimicrobial Resistance">CVM GFI #144 (VICH GL27) Pre-Approval Information for Registration of New Veterinary Medicinal Products for Food-Producing Animals with Respect to Antimicrobial Resistance</a><br>April 27, 2004</li><li><a href="/regulatory-information/search-fda-guidance-documents/bioanalytical-method-validation-guidance-industry" data-entity-type="node" data-entity-uuid="edb4960a-9629-4e2d-a258-bcef45d7a212" data-entity-substitution="canonical" title="Bioanalytical Method Validation Guidance for Industry">CVM GFI #145 Bioanalytical Method Validation </a></li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-147-vich-gl31-studies-evaluate-safety-residues-veterinary-drugs-human-food-repeat-dose-90" data-entity-type="node" data-entity-uuid="bbf97579-99cf-4072-b5fc-1961ac8f5538" data-entity-substitution="canonical" title="CVM GFI #147 (VICH GL31) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Repeat-Dose (90 Day) Toxicity Testing">CVM GFI #147 (VICH GL31) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Repeat-Dose (90 Day) Toxicity Testing</a><br>July 27, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-148-vich-gl32-studies-evaluate-safety-residues-veterinary-drugs-human-food-developmental" data-entity-type="node" data-entity-uuid="bf126569-3a34-482d-9bcb-24d025cfc8a2" data-entity-substitution="canonical" title="CVM GFI #148 (VICH GL32) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Developmental Toxicity Testing">CVM GFI #148 (VICH GL32) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Developmental Toxicity Testing</a><br>July 27, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-149-vich-gl33-studies-evaluate-safety-residues-veterinary-drugs-human-food-general-approach" data-entity-type="node" data-entity-uuid="805ca015-1222-4253-86b1-05e18c2870e3" data-entity-substitution="canonical" title="CVM GFI #149 (VICH GL33) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Testing">CVM GFI #149 (VICH GL33) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Testing</a><br>March 17, 2009</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-150-concerns-related-use-clove-oil-anesthetic-fish" data-entity-type="node" data-entity-uuid="2e301fd0-fe51-4af3-a880-e7d286a22ee6" data-entity-substitution="canonical" title="CVM GFI #150 Concerns Related to the use of Clove Oil as an Anesthetic for Fish">CVM GFI #150 Concerns Related to the use of Clove Oil as an Anesthetic for Fish</a><br>April 24, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/fda-export-certification" data-entity-type="node" data-entity-uuid="c4622986-73d1-4c36-98ae-9c811acf2459" data-entity-substitution="canonical" title="FDA Export Certification">CVM GFI #151 FDA Export Certificates</a><br>July 12, 2004</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-152-evaluating-safety-antimicrobial-new-animal-drugs-regard-their-microbiological-effects" data-entity-type="node" data-entity-uuid="2532f078-ddd7-42c4-8db0-4244b21f8154" data-entity-substitution="canonical" title="CVM GFI #152 Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern">CVM GFI #152 Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern</a><br>January 27, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-156-comparability-protocols-chemistry-manufacturing-and-controls-information-new-animal" data-entity-type="node" data-entity-uuid="7a55a421-bbd3-485b-bedd-9adccaecfdaa" data-entity-substitution="canonical" title="CVM GFI #156 Comparability Protocols - Chemistry, Manufacturing, and Controls Information for New Animal Drugs">CVM GFI #156 Comparability Protocols - Chemistry, Manufacturing, and Controls Information for New Animal Drugs</a><br>April 4, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-158-use-material-deer-and-elk-animal-feed" data-entity-type="node" data-entity-uuid="0737c154-fac9-4731-8457-5269202fb1c4" data-entity-substitution="canonical" title="CVM GFI #158 Use of Material from Deer and Elk in Animal Feed">CVM GFI #158 Use of Material from Deer and Elk in Animal Feed</a><br>March 16, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-159-vich-gl36-studies-evaluate-safety-residues-veterinary-drugs-human-food-general-approach" data-entity-type="node" data-entity-uuid="f8e450dc-a0ef-4f55-8b08-0537e87a3f30" data-entity-substitution="canonical" title="CVM GFI #159 (VICH GL36) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish a Microbiological ADI">CVM GFI #159 (VICH GL36) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish a Microbiological ADI</a><br>January 21, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-160-vich-gl37-studies-evaluate-safety-residues-veterinary-drugs-human-food-repeat-dose" data-entity-type="node" data-entity-uuid="b5aebdb4-3375-47e3-9743-d8247d164cdc" data-entity-substitution="canonical" title="CVM GFI #160 (VICH GL37) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Repeat-Dose (Chronic) Toxicity Testing">CVM GFI #160 (VICH GL37) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Repeat-Dose (Chronic) Toxicity Testing</a><br>July 27, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-166-vich-gl38-environmental-impact-assessments-eias-veterinary-medicinal-products-vmps-phase" data-entity-type="node" data-entity-uuid="89b6c4e5-6596-42c1-8b3c-057dfac69c0c" data-entity-substitution="canonical" title="CVM GFI #166 (VICH GL38) Environmental Impact Assessments (EIA's) for Veterinary Medicinal Products (VMP’s) - Phase II">CVM GFI #166 (VICH GL38) Environmental Impact Assessments (EIA's) for Veterinary Medicinal Products (VMP’s) - Phase II</a><br>January 9, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-169-drug-substance-chemistry-manufacturing-and-controls-information" data-entity-type="node" data-entity-uuid="06b909ed-39b1-4a0a-a124-33d5a45916fe" data-entity-substitution="canonical" title="CVM GFI #169 Drug Substance Chemistry, Manufacturing, and Controls Information">CVM GFI #169 Drug Substance Chemistry, Manufacturing, and Controls Information</a><br>August 6, 2010</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-170-animal-drug-user-fees-and-fee-waivers-and-reductions" data-entity-type="node" data-entity-uuid="5d0901ae-ed2a-4240-8090-4de9b14eeea7" data-entity-substitution="canonical" title="CVM GFI #170 Animal Drug User Fees and Fee Waivers and Reductions">CVM GFI #170 Animal Drug User Fees and Fee Waivers and Reductions</a><br>April 13, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-171-demonstrating-bioequivalence-soluble-powder-oral-dosage-form-products-and-type-medicated" data-entity-type="node" data-entity-uuid="f47713ed-1894-456d-901c-0d727fbc42c2" data-entity-substitution="canonical" title="CVM GFI #171 - Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated Articles Containing Active Pharmaceutical Ingredients Considered to Be Soluble in Aqueous Media">CVM GFI #171 - Demonstrating Bioequivalence for Soluble Powder Oral Dosage Form Products and Type A Medicated Articles Containing Active Pharmaceutical Ingredients Considered to Be Soluble in Aqueous Media</a><br>June 16, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-173-animal-drug-sponsor-fees-under-animal-drug-user-fee-act-adufa" data-entity-type="node" data-entity-uuid="194e0b4a-9e40-4351-b458-6f3e43d4775d" data-entity-substitution="canonical" title="CVM GFI #173 Animal Drug Sponsor Fees Under the Animal Drug User Fee Act (ADUFA)">CVM GFI #173 Animal Drug Sponsor Fees Under the Animal Drug User Fee Act (ADUFA)</a><br>February 7, 2005</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-173-appendix-animal-drug-sponsor-fees-under-adufa" data-entity-type="node" data-entity-uuid="3c51f533-93f1-4a9c-b21a-58f1dbb76e90" data-entity-substitution="canonical" title="CVM GFI #173 Appendix for the Animal Drug Sponsor Fees Under ADUFA">CVM GFI #173 Appendix for the Animal Drug Sponsor Fees Under ADUFA</a><br>February 7, 2005</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-176-vich-gl39-specifications-test-procedures-and-acceptance-criteria-new-veterinary-drug" data-entity-type="node" data-entity-uuid="1b03ce2f-58bf-4efa-b950-7c6e7afa623f" data-entity-substitution="canonical" title="CVM GFI #176 (VICH GL39) Specifications: Test Procedures and Acceptance Criteria for New Veterinary Drug Substances and New Medicinal Products: Chemical Substances">CVM GFI #176 (VICH GL39) Specifications: Test Procedures and Acceptance Criteria for New Veterinary Drug Substances and New Medicinal Products: Chemical Substances</a><br>June 14, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-177-vich-gl40-test-proceduresacceptance-criteria-new-biotechnologicalbiological-veterinary" data-entity-type="node" data-entity-uuid="a78d9c85-a640-4610-aa9b-ebadf5959385" data-entity-substitution="canonical" title="CVM GFI #177 (VICH GL40) Test Procedures/Acceptance Criteria for New Biotechnological/Biological Veterinary Medicinal Products">CVM GFI #177 (VICH GL40) Test Procedures/Acceptance Criteria for New Biotechnological/Biological Veterinary Medicinal Products</a><br>June 14, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-178-recommended-design-and-evaluation-effectiveness-studies-swine-respiratory-disease-claims" data-entity-type="node" data-entity-uuid="bb882650-23f9-4b6e-9883-32f0f57f598d" data-entity-substitution="canonical" title="CVM GFI #178 Recommended Design and Evaluation of Effectiveness Studies for Swine Respiratory Disease Claims">CVM GFI #178 Recommended Design and Evaluation of Effectiveness Studies for Swine Respiratory Disease Claims</a><br>October 1, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-179-use-animal-clones-and-clone-progeny-human-food-and-animal-feed" data-entity-type="node" data-entity-uuid="edd470e3-400b-4069-a7fa-809617e75483" data-entity-substitution="canonical" title="CVM GFI #179 Use of Animal Clones and Clone Progeny for Human Food and Animal Feed">CVM GFI #179 Use of Animal Clones and Clone Progeny for Human Food and Animal Feed</a><br>January 15, 2008</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-181-blue-bird-medicated-feed-labels" data-entity-type="node" data-entity-uuid="5727e676-4062-44ad-b946-ac0c9dcd57b6" data-entity-substitution="canonical" title="CVM GFI #181 Blue Bird Medicated Feed Labels">CVM GFI #181 Blue Bird Medicated Feed Labels</a><br>July 23, 2019</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-183-animal-drug-user-fees-fees-exceed-costs-waiverreduction" data-entity-type="node" data-entity-uuid="fa017554-ce19-4443-a488-f01f36522db7" data-entity-substitution="canonical" title="CVM GFI #183 Animal Drug User Fees: Fees Exceed Costs Waiver/Reduction">CVM GFI #183 Animal Drug User Fees: Fees Exceed Costs Waiver/Reduction</a><br>March 9, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-185-vich-gl43-target-animal-safety-veterinary-pharmaceutical-products" data-entity-type="node" data-entity-uuid="199fa489-57c9-4c99-849f-3b2c8ba2f2e9" data-entity-substitution="canonical" title="CVM GFI #185 (VICH GL43) Target Animal Safety for Veterinary Pharmaceutical Products">CVM GFI #185 (VICH GL43) Target Animal Safety for Veterinary Pharmaceutical Products</a><br>April 24, 2009</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-187a-heritable-intentional-genomic-alterations-animals-risk-based-approach" data-entity-type="node" data-entity-uuid="cd4ea56b-7709-4ce5-b087-95f9d05bb49a" data-entity-substitution="canonical" title="CVM GFI #187A Heritable Intentional Genomic Alterations in Animals: Risk-Based Approach">CVM GFI #187A Heritable Intentional Genomic Alterations in Animals: Risk-Based Approach</a><br>May 2, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-187b-heritable-intentional-genomic-alterations-animals-approval-process" data-entity-type="node" data-entity-uuid="7fa468b8-843a-4601-a555-e5539f648691" data-entity-substitution="canonical" title="CVM GFI #187B Heritable Intentional Genomic Alterations in Animals: The Approval Process">CVM GFI #187B Heritable Intentional Genomic Alterations in Animals: The Approval Process</a><br>January 7, 2025</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-188-data-elements-submission-veterinary-adverse-event-reports-center-veterinary-medicine" data-entity-type="node" data-entity-uuid="05d75db5-e266-441d-a3bd-23b89b25c45a" data-entity-substitution="canonical" title="CVM GFI #188 Data Elements for Submission of Veterinary Adverse Event Reports to the Center for Veterinary Medicine">CVM GFI #188 Data Elements for Submission of Veterinary Adverse Event Reports to the Center for Veterinary Medicine</a><br>January 31, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-191-changes-approved-nadas-new-nadas-vs-category-ii-supplemental-nadas" data-entity-type="node" data-entity-uuid="30275d7d-f1df-4614-afc9-95ccb5de5493" data-entity-substitution="canonical" title="CVM GFI #191 Changes to Approved NADAs - New NADAs vs. Category II Supplemental NADAs">CVM GFI #191 Changes to Approved NADAs - New NADAs vs. Category II Supplemental NADAs</a><br>August 27, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-192-anesthetics-companion-animals" data-entity-type="node" data-entity-uuid="7686ca6c-19fb-45ac-81fb-b00eb7a8e071" data-entity-substitution="canonical" title="CVM GFI #192 Anesthetics for Companion Animals">CVM GFI #192 Anesthetics for Companion Animals</a><br>March 25, 2010</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-195-small-entities-compliance-guide-renderers-substances-prohibited-use-animal-food-or-feed" data-entity-type="node" data-entity-uuid="d14047a2-02c2-45c4-bf10-f4927cd5735e" data-entity-substitution="canonical" title="CVM GFI #195 Small Entities Compliance Guide For Renderers—Substances Prohibited From Use In Animal Food Or Feed">CVM GFI #195 Small Entities Compliance Guide For Renderers—Substances Prohibited From Use In Animal Food Or Feed</a><br>May 6, 2009</li><li><a href="/regulatory-information/search-fda-guidance-documents/process-validation-general-principles-and-practices" data-entity-type="node" data-entity-uuid="8ba58be1-9b1a-4b68-9ab4-4e99ca237785" data-entity-substitution="canonical" title="Process Validation: General Principles and Practices">CVM GFI #196 Process Validation: General Principles and Practices</a><br>January 24, 2011</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-197-documenting-electronic-data-files-and-statistical-analysis-programs" data-entity-type="node" data-entity-uuid="a65aa6ad-9391-43fd-b9d2-a98b16c6b650" data-entity-substitution="canonical" title="CVM GFI #197 Documenting Electronic Data Files and Statistical Analysis Programs">CVM GFI #197 Documenting Electronic Data Files and Statistical Analysis Programs</a><br>November 13, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-198-vich-gl45-bracketing-and-matrixing-designs-stability-testing-new-veterinary-drug" data-entity-type="node" data-entity-uuid="d86ec67c-cf43-4f02-b93e-5d463dbe87e0" data-entity-substitution="canonical" title="CVM GFI #198 (VICH GL45) Bracketing and Matrixing Designs For Stability Testing of New Veterinary Drug Substances and Medicinal Products">CVM GFI #198 (VICH GL45) Bracketing and Matrixing Designs For Stability Testing of New Veterinary Drug Substances and Medicinal Products</a><br>July 31, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-199-animal-generic-drug-user-fees-and-fee-waivers-and-reductions" data-entity-type="node" data-entity-uuid="18b466e9-5382-485d-8fbc-818b76219d0a" data-entity-substitution="canonical" title="CVM GFI #199 Animal Generic Drug User Fees and Fee Waivers and Reductions">CVM GFI #199 Animal Generic Drug User Fees and Fee Waivers and Reductions</a><br>December 4, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-200-secg-designation-new-animal-drugs-minor-uses-or-minor-species" data-entity-type="node" data-entity-uuid="8f8316b4-5013-4d8c-8122-5b016abb7daa" data-entity-substitution="canonical" title="CVM GFI #200 SECG for Designation of New Animal Drugs for Minor Uses or Minor Species">CVM GFI #200 - Small Entities Compliance Guide Designation of New Animal Drugs for Minor Uses or Minor Species</a><br>July 29, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-201-secg-index-legally-marketed-unapproved-new-animal-drugs-minor-species" data-entity-type="node" data-entity-uuid="ae87444d-bc00-469c-87fd-853bd13fb29e" data-entity-substitution="canonical" title="CVM GFI #201 SECG for The Index of Legally Marketed Unapproved New Animal Drugs for Minor Species">CVM GFI #201 SECG for The Index of Legally Marketed Unapproved New Animal Drugs for Minor Species</a><br>July 29, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-203-ensuring-safety-animal-feed-maintained-and-fed-farm" data-entity-type="node" data-entity-uuid="ef5cec19-a1a5-4dc9-9983-27e5ed4be654" data-entity-substitution="canonical" title="CVM GFI #203 Ensuring Safety of Animal Feed Maintained and Fed On-Farm">CVM GFI #203 Ensuring Safety of Animal Feed Maintained and Fed On-Farm</a><br>March 9, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-204-active-controls-studies-demonstrate-effectiveness-new-animal-drug-use-companion-animals" data-entity-type="node" data-entity-uuid="b99a588e-2fc4-48fb-9262-9bebb4453086" data-entity-substitution="canonical" title="CVM GFI #204 Active Controls in Studies to Demonstrate Effectiveness of a New Animal Drug for use in Companion Animals">CVM GFI #204 Active Controls in Studies to Demonstrate Effectiveness of a New Animal Drug for use in Companion Animals</a><br>December 1, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-205-vich-gl46-studies-evaluate-metabolism-and-residue-kinetics-veterinary-drugs-food" data-entity-type="node" data-entity-uuid="96f4cacd-02c0-41ce-8ca8-48809abf0754" data-entity-substitution="canonical" title="CVM GFI #205 (VICH GL46) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Animals: Metabolism Study to Determine the Quantity and Identify the Nature of Residues (MRK)">CVM GFI #205 (VICH GL46) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Animals:  Metabolism Study to Determine the Quantity and Identify the Nature of Residues (MRK)</a><br>September 15, 2011</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-206-vich-gl47-studies-evaluate-metabolism-and-residue-kinetics-veterinary-drugs-food" data-entity-type="node" data-entity-uuid="cf05e0fe-7477-45b8-b9fc-bd735334da58" data-entity-substitution="canonical" title="CVM GFI #206 (VICH GL47) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Animals: Comparative Metabolism Studies in Laboratory Animals">CVM GFI #206 (VICH GL47) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Animals: Comparative Metabolism Studies in Laboratory Animals</a><br>September 15, 2011</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-207-vich-gl48-studies-evaluate-metabolism-and-residue-kinetics-veterinary-drugs-food" data-entity-type="node" data-entity-uuid="76c2fa66-6630-4bf9-a643-2ab609640680" data-entity-substitution="canonical" title="CVM GFI #207 (VICH GL48) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs In Food-Producing Animals: Marker Residue Depletion Studies to Establish Product Withdrawal Periods">CVM GFI #207 (VICH GL48) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs In Food-Producing Animals: Marker Residue Depletion Studies to Establish Product Withdrawal Periods</a><br>March 9, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-208-vich-gl49-studies-evaluate-metabolism-and-residue-kinetics-veterinary-drugs-food" data-entity-type="node" data-entity-uuid="dc8907af-ebde-4cc7-a905-7c116d78fa4c" data-entity-substitution="canonical" title="CVM GFI #208 (VICH GL49) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Animals: Validation of Analytical Methods Used in Residue Depletion Studies">CVM GFI #208 (VICH GL49) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Animals: Validation of Analytical Methods Used in Residue Depletion Studies</a><br>March 9, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-209-judicious-use-medically-important-antimicrobial-drugs-food-producing-animals" data-entity-type="node" data-entity-uuid="ffc434eb-7f52-47ca-a3ff-92c16137a23e" data-entity-substitution="canonical" title="CVM GFI #209 The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals">CVM GFI #209 The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals</a><br>April 13, 2012</li><li><a href="/regulatory-information/search-fda-guidance-documents/fdas-strategy-antimicrobial-resistance-questions-and-answers" data-entity-type="node" data-entity-uuid="c6e44ffe-002d-4a54-a0ae-e8c9da357ebb" data-entity-substitution="canonical" title="FDA's Strategy on Antimicrobial Resistance - Questions and Answers">FDA's Strategy on Antimicrobial Resistance - Questions and Answers</a><br>December 11, 2013</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-211-residual-solvents-animal-drug-products-questions-and-answers" data-entity-type="node" data-entity-uuid="67935d5d-08b9-4ddb-bf07-2717bea7f88c" data-entity-substitution="canonical" title="CVM GFI #211 Residual Solvents in Animal Drug Products Questions and Answers">CVM GFI #211 Residual Solvents in Animal Drug Products Questions and Answers</a><br>April 3, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-213-new-animal-drugs-and-new-animal-drug-combination-products-administered-or-medicated-feed" data-entity-type="node" data-entity-uuid="9528d8a6-0d80-4f36-8aa6-780926b901e2" data-entity-substitution="canonical" title="CVM GFI #213 New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions with GFI #209">CVM GFI #213 New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions with GFI #209</a><br>December 12, 2013</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-214-vich-gl35-pharmacovigilance-veterinary-medicinal-products-electronic-standards-transfer" data-entity-type="node" data-entity-uuid="ab999fca-1829-4fc2-94ef-e731b23062f3" data-entity-substitution="canonical" title="CVM GFI #214 (VICH GL35) Pharmacovigilance of Veterinary Medicinal Products Electronic Standards for Transfer of Data">CVM GFI #214 (VICH GL35) Pharmacovigilance of Veterinary Medicinal Products Electronic Standards for Transfer of Data</a><br>January 31, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-215-target-animal-safety-effectiveness-protocol-development-submission" data-entity-type="node" data-entity-uuid="b5798f96-a5c5-498a-ad43-b7e0c5ba22b2" data-entity-substitution="canonical" title="CVM GFI #215 Target Animal Safety & Effectiveness Protocol Development & Submission">CVM GFI #215 Target Animal Safety and Effectiveness Protocol Development and Submission</a><br>September 29, 2011</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-216-chemistry-manufacturing-and-controls-cmc-information-fermentation-derived-intermediates" data-entity-type="node" data-entity-uuid="72af7145-cc31-4233-a9e8-4f5be9a848bc" data-entity-substitution="canonical" title="CVM GFI #216 Chemistry, Manufacturing, and Controls (CMC) Information - Fermentation-Derived Intermediates, Drug Substances, and Related Drug Products for Veterinary Medicinal Use">CVM GFI #216 Chemistry, Manufacturing, and Controls (CMC) Information - Fermentation-Derived Intermediates, Drug Substances, and Related Drug Products for Veterinary Medicinal Use</a><br>March 8, 2012</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-217-evaluating-effectiveness-anticoccidial-drugs-food-producing-animals" data-entity-type="node" data-entity-uuid="593dad74-20b1-40dc-b767-db75c3f56882" data-entity-substitution="canonical" title="CVM GFI #217 Evaluating the Effectiveness of Anticoccidial Drugs in Food-Producing Animals">CVM GFI #217 Evaluating the Effectiveness of Anticoccidial Drugs in Food-Producing Animals</a><br>November 20, 2012</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-218-cell-based-products-animal-use" data-entity-type="node" data-entity-uuid="699a305e-c914-4fb6-a479-38f5ef9c5857" data-entity-substitution="canonical" title="CVM GFI #218 Cell-Based Products for Animal Use">CVM GFI #218 Cell-Based Products for Animal Use</a><br>June 12, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-219-vich-gl51-statistical-evaluation-stability-data" data-entity-type="node" data-entity-uuid="5202f5ed-a455-4fca-8ef4-56971074766e" data-entity-substitution="canonical" title="CVM GFI #219 (VICH GL51) Statistical Evaluation of Stability Data">CVM GFI #219 (VICH GL51) Statistical Evaluation of Stability Data</a><br>May 13, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-220-use-nanomaterials-food-animals" data-entity-type="node" data-entity-uuid="faef172a-82fc-47af-93e5-d6d9b259a554" data-entity-substitution="canonical" title="CVM GFI #220 Use of Nanomaterials in Food for Animals">CVM GFI #220 Use of Nanomaterials in Food for Animals</a><br>August 5, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-221-recommendations-preparation-and-submission-animal-food-additive-petitions" data-entity-type="node" data-entity-uuid="22b65d1c-e699-4d1b-9e1a-8077c5e13e5a" data-entity-substitution="canonical" title="CVM GFI #221 Recommendations for Preparation and Submission of Animal Food Additive Petitions">CVM GFI #221 Recommendations for Preparation and Submission of Animal Food Additive Petitions</a><br>June 12, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-223-small-entity-compliance-guide-declaring-color-additives-animal-foods" data-entity-type="node" data-entity-uuid="2a762a78-cad8-4a6e-a13f-22ce4fe93942" data-entity-substitution="canonical" title="CVM GFI #223 Small Entity Compliance Guide Declaring Color Additives in Animal Foods">CVM GFI #223 Small Entity Compliance Guide Declaring Color Additives in Animal Foods</a><br>September 27, 2013</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-224-vich-gl52-bioequivalence-blood-level-bioequivalence-study" data-entity-type="node" data-entity-uuid="ab5b9815-8a1a-42e4-86c8-c95f9962eee1" data-entity-substitution="canonical" title="CVM GFI #224 (VICH GL52) Bioequivalence: Blood Level Bioequivalence Study">CVM GFI #224 (VICH GL52) Bioequivalence: Blood Level Bioequivalence Study</a><br>December 16, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-224-supplement-vich-gl52-supplemental-examples-illustrating-statistical-concepts-described" data-entity-type="node" data-entity-uuid="efec3eb6-1185-4131-881a-5195763f0f2b" data-entity-substitution="canonical" title="CVM GFI #224 (Supplement to VICH GL52) Supplemental Examples For Illustrating Statistical Concepts Described in the VICH In Vivo Bioequivalence Guidance GL52">CVM GFI #224 (Supplement to VICH GL52) Supplemental Examples For Illustrating Statistical Concepts Described in the VICH In Vivo Bioequivalence Guidance GL52</a><br>September 24, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-225-vich-gl53-electronic-exchange-documents-file-format-recommendations" data-entity-type="node" data-entity-uuid="7db9f8cf-ac14-4dcb-b11a-bcae3594d18e" data-entity-substitution="canonical" title="CVM GFI #225 (VICH GL53) Electronic Exchange of Documents: File Format Recommendations">CVM GFI #225 (VICH GL53) Electronic Exchange of Documents: File Format Recommendations</a><br>September 1, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-226-target-animal-safety-data-presentation-and-statistical-analysis" data-entity-type="node" data-entity-uuid="633a147f-3834-4a2f-a668-8a55dc716634" data-entity-substitution="canonical" title="CVM GFI #226 Target Animal Safety Data Presentation and Statistical Analysis">CVM GFI #226 Target Animal Safety Data Presentation and Statistical Analysis</a><br>January 21, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-227-chemistry-manufacturing-and-controls-cmc-technical-section-filing-strategies" data-entity-type="node" data-entity-uuid="af29c9e1-c73b-4a5f-a0ba-cd46df7c447a" data-entity-substitution="canonical" title="CVM GFI #227 Chemistry, Manufacturing, and Controls (CMC) Technical Section Filing Strategies">CVM GFI #227 Chemistry, Manufacturing, and Controls (CMC) Technical Section Filing Strategies</a><br>September 17, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-229-evaluating-effectiveness-new-animal-drugs-reduction-pathogenic-shiga-toxin-producing-e" data-entity-type="node" data-entity-uuid="f7546f50-c0f6-4b53-82b3-f534672ad388" data-entity-substitution="canonical" title="CVM GFI #229 Evaluating the Effectiveness of New Animal Drugs for the Reduction of Pathogenic Shiga Toxin-Producing E. coli in Cattle">CVM GFI #229 Evaluating the Effectiveness of New Animal Drugs for the Reduction of Pathogenic Shiga Toxin-Producing E. coli in Cattle</a><br>October 19, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-231-distributor-labeling-new-animal-drugs" data-entity-type="node" data-entity-uuid="db68782e-b899-4c7b-a36e-db959cfbec3e" data-entity-substitution="canonical" title="CVM GFI #231 Distributor Labeling for New Animal Drugs">CVM GFI #231 Distributor Labeling for New Animal Drugs</a><br>April 20, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-232-vich-gl54-studies-evaluate-safety-residues-veterinary-drugs-human-food-general-approach" data-entity-type="node" data-entity-uuid="34723505-0e6f-4ce3-9c95-753305edb00c" data-entity-substitution="canonical" title="CVM GFI #232 (VICH GL54) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish an Acute Reference Dose (ARfD)">CVM GFI #232 (VICH GL54) Studies to Evaluate the Safety of Residues of Veterinary Drugs in Human Food: General Approach to Establish an Acute Reference Dose (ARfD)</a><br>August 23, 2017</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-233-veterinary-feed-directive-common-format-questions-and-answers" data-entity-type="node" data-entity-uuid="295e81ba-766c-4b31-aaf7-af5f751338e8" data-entity-substitution="canonical" title="CVM GFI #233 Veterinary Feed Directive Common Format Questions and Answers">CVM GFI #233 Veterinary Feed Directive Common Format Questions and Answers</a><br>September 22, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-234-question-based-review-chemistry-manufacturing-and-controls-technical-section-animal-drug" data-entity-type="node" data-entity-uuid="ddd0a607-8660-44d8-9840-3884c82bfa7d" data-entity-substitution="canonical" title="CVM GFI #234 Question-Based Review for the Chemistry, Manufacturing, and Controls Technical Section of Animal Drug Applications">CVM GFI #234 Question-Based Review for the Chemistry, Manufacturing, and Controls Technical Section of Animal Drug Applications</a><br>December 20, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-235-current-good-manufacturing-practice-requirements-food-animals" data-entity-type="node" data-entity-uuid="b7d763a6-0bef-4507-9287-35d548a7a0f4" data-entity-substitution="canonical" title="CVM GFI #235 Current Good Manufacturing Practice Requirements for Food for Animals">CVM GFI #235 Current Good Manufacturing Practice Requirements for Food for Animals</a><br>October 20, 2017</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-236-clarification-fda-and-epa-jurisdiction-over-mosquito-related-products" data-entity-type="node" data-entity-uuid="7d65f383-f0b7-4c46-9e39-2e8bd9fb593e" data-entity-substitution="canonical" title="CVM GFI #236 Clarification of FDA and EPA Jurisdiction Over Mosquito-Related Products">CVM GFI #236 Clarification of FDA and EPA Jurisdiction Over Mosquito-Related Products</a><br>October 5, 2017</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-237-oncology-drugs-companion-animals" data-entity-type="node" data-entity-uuid="08e553c8-91fb-448d-8929-d482711e4658" data-entity-substitution="canonical" title="CVM GFI #237 Oncology Drugs for Companion Animals">CVM GFI #237 Oncology Drugs for Companion Animals</a><br>August 23, 2017</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-238-modified-release-veterinary-parenteral-dosage-forms-development-evaluation-and" data-entity-type="node" data-entity-uuid="70485b87-30c6-4e2d-b115-47efde57ada5" data-entity-substitution="canonical" title="CVM GFI #238 Modified Release Veterinary Parenteral Dosage Forms: Development, Evaluation, and Establishment of Specifications">CVM GFI #238 Modified Release Veterinary Parenteral Dosage Forms: Development, Evaluation, and Establishment of Specifications</a><br>June 17, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-239-human-food-products-use-animal-food" data-entity-type="node" data-entity-uuid="bb7c650c-2ed1-4753-aa4d-b6701c2f26dd" data-entity-substitution="canonical" title="CVM GFI #239 Human Food By-Products For Use As Animal Food">CVM GFI #239 Human Food By-Products For Use As Animal Food</a><br>August 25, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-240-proprietary-names-new-animal-drugs" data-entity-type="node" data-entity-uuid="3d050858-99b8-4b21-951a-911ba07fec3e" data-entity-substitution="canonical" title="CVM GFI #240 Proprietary Names for New Animal Drugs">CVM GFI #240 Proprietary Names for New Animal Drugs</a><br>June 1, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-241-small-entity-compliance-guide-what-you-need-know-about-fda-regulation-current-good" data-entity-type="node" data-entity-uuid="1ddf31c4-ba68-4434-98a5-daa26cd3a09c" data-entity-substitution="canonical" title="CVM GFI #241 Small Entity Compliance Guide – What You Need to Know About the FDA Regulation: Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals (21 CFR Part 507)">CVM GFI #241 Small Entity Compliance Guide – What You Need to Know About the FDA Regulation: Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals (21 CFR Part 507)</a><br>November 1, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-242-use-stability-studies-and-associated-labeling-statements-multiple-dose-injectable-animal" data-entity-type="node" data-entity-uuid="0e70e2f9-b924-49f3-8493-433272d48fa7" data-entity-substitution="canonical" title="CVM GFI #242 In-Use Stability Studies and Associated Labeling Statements for Multiple-Dose Injectable Animal Drug Products">CVM GFI #242 In-Use Stability Studies and Associated Labeling Statements for Multiple-Dose Injectable Animal Drug Products</a><br>November 27, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-243-vich-gl56-studies-evaluate-metabolism-and-residue-kinetics-veterinary-drugs-food" data-entity-type="node" data-entity-uuid="34681480-fa1c-4e5f-ae07-9823dd0a5625" data-entity-substitution="canonical" title="CVM GFI #243 (VICH GL56) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Species: Study Design Recommendations for Residue Studies in Honey for Establishing Maximum Residue Limits and Withdrawal Periods">CVM GFI #243 (VICH GL56) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Species: Study Design Recommendations for Residue Studies in Honey for Establishing Maximum Residue Limits and Withdrawal Periods</a><br>November 14, 2018</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-245-hazard-analysis-and-risk-based-preventive-controls-food-animals" data-entity-type="node" data-entity-uuid="627ac09b-48e6-4dfd-a44f-6f256a092c8c" data-entity-substitution="canonical" title="CVM GFI #245 Hazard Analysis and Risk-Based Preventive Controls for Food for Animals">CVM GFI #245 Hazard Analysis and Risk-Based Preventive Controls for Food for Animals</a><br>July 8, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-246-hazard-analysis-and-risk-based-preventive-controls-food-animals-supply-chain-program" data-entity-type="node" data-entity-uuid="9e463cf1-2539-4553-bf2d-3ec9d6cfda3a" data-entity-substitution="canonical" title="CVM GFI #246 Hazard Analysis and Risk-Based Preventive Controls for Food for Animals: Supply-Chain Program">CVM GFI #246 Hazard Analysis and Risk-Based Preventive Controls for Food for Animals: Supply-Chain Program</a><br>June 15, 2018</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-251-heritable-intentional-genomic-alterations-animals-food-producing-species-use-models" data-entity-type="node" data-entity-uuid="92c37bfe-4950-4aef-a795-0572938a1075" data-entity-substitution="canonical" title="CVM GFI #251 - Heritable Intentional Genomic Alterations in Animals of Food-Producing Species for Use as Models of Disease">CVM GFI #251 - Heritable Intentional Genomic Alterations in Animals of Food-Producing Species for Use as Models of Disease</a><br>January 7, 2025</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-252-small-entity-compliance-guide-antimicrobial-animal-drug-sales-and-distribution-reporting" data-entity-type="node" data-entity-uuid="daa4cb1d-f6e1-4a1d-b1e5-effc300aa662" data-entity-substitution="canonical" title="CVM GFI #252 Small Entity Compliance Guide Antimicrobial Animal Drug Sales and Distribution Reporting">CVM GFI #252 Small Entity Compliance Guide Antimicrobial Animal Drug Sales and Distribution Reporting</a><br>June 29, 2018</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-253-current-good-manufacturing-practice-animal-cells-tissues-and-cell-and-tissue-based" data-entity-type="node" data-entity-uuid="80e10d61-bd79-4947-92c0-00a3e1722b94" data-entity-substitution="canonical" title="CVM GFI #253 Current Good Manufacturing Practice for Animal Cells, Tissues, and Cell- and Tissue-Based Products">CVM GFI #253 Current Good Manufacturing Practice for Animal Cells, Tissues, and Cell- and Tissue-Based Products</a><br>October 20, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-254-donor-eligibility-animal-cells-tissues-and-cell-and-tissue-based-products" data-entity-type="node" data-entity-uuid="227598ba-5c3c-49d5-98ab-46ce26d4421d" data-entity-substitution="canonical" title="CVM GFI #254 Donor Eligibility for Animal Cells, Tissues, and Cell- and Tissue-Based Products">CVM GFI #254 Donor Eligibility for Animal Cells, Tissues, and Cell- and Tissue-Based Products</a><br>October 20, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-255-elemental-impurities-animal-drug-products-questions-and-answers" data-entity-type="node" data-entity-uuid="afa5d3ca-0fb0-485c-a655-37a5db282bc9" data-entity-substitution="canonical" title="CVM GFI #255 Elemental Impurities in Animal Drug Products Questions and Answers">CVM GFI #255 Elemental Impurities in Animal Drug Products Questions and Answers</a><br>November 23, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-256-compounding-animal-drugs-bulk-drug-substances" data-entity-type="node" data-entity-uuid="0a9b0c67-cfee-4071-a70f-60934c159be4" data-entity-substitution="canonical" title="CVM GFI #256 - Compounding Animal Drugs from Bulk Drug Substances">CVM GFI #256 Compounding Animal Drugs from Bulk Drug Substances</a><br>August 10, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-257-vich-gl57-studies-evaluate-metabolism-and-residue-kinetics-veterinary-drugs-food" data-entity-type="node" data-entity-uuid="2274d417-6e34-4029-aa3b-8c4fd5e1e798" data-entity-substitution="canonical" title="CVM GFI #257 (VICH GL57) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Species: Marker Residue Depletion Studies to Establish Product Withdrawal Periods in Aquatic Species">CVM GFI #257 (VICH GL57) Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-Producing Species: Marker Residue Depletion Studies to Establish Product Withdrawal Periods in Aquatic Species</a><br>August 19, 2019</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-258-use-tracers-animal-food-type-medicated-articles-and-medicated-feeds" data-entity-type="node" data-entity-uuid="c4bb1e56-d65d-4595-9777-74d17e6bbb16" data-entity-substitution="canonical" title="CVM GFI #258 Use of Tracers in Animal Food, Type A Medicated Articles, and Medicated Feeds">CVM GFI #258 Use of Tracers in Animal Food, Type A Medicated Articles, and Medicated Feeds</a><br>October 19, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-259-vich-gl58-stability-testing-new-veterinary-drug-substances-and-medicinal-products" data-entity-type="node" data-entity-uuid="62085b6f-1ee0-4cab-a2fd-3b796dc04b12" data-entity-substitution="canonical" title="CVM GFI #259 (VICH GL58) Stability Testing of New Veterinary Drug Substances and Medicinal Products in Climatic Zones III and IV">CVM GFI #259 (VICH GL58) Stability Testing of New Veterinary Drug Substances and Medicinal Products in Climatic Zones III and IV</a><br>April 14, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-260-type-vii-veterinary-master-file-research-and-development-and-risk-reviews" data-entity-type="node" data-entity-uuid="12ab5824-7169-456d-9f7f-688aa892e9d8" data-entity-substitution="canonical" title="CVM GFI #260 - Type VII Veterinary Master File for Research and Development and Risk Reviews">CVM GFI #260 - Type VII Veterinary Master File for Research and Development and Risk Reviews</a><br>January 7, 2025</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-261-eligibility-criteria-expanded-conditional-approval-new-animal-drugs" data-entity-type="node" data-entity-uuid="0e025b46-9ce1-4161-bda8-61edcd0254e4" data-entity-substitution="canonical" title="CVM GFI #261 - Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs ">CVM GFI #261 Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs</a><br>July 14, 2021</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-262-pre-submission-consultation-process-animal-food-additive-petitions-or-generally" data-entity-type="node" data-entity-uuid="0b78dfbc-a7ea-4fef-9e2c-7e8cc43275f5" data-entity-substitution="canonical" title="CVM GFI #262 Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe (GRAS) Notices">CVM GFI #262 Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe (GRAS) Notices</a><br>December 11, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-263-recommendations-sponsors-medically-important-antimicrobial-drugs-approved-use-animals" data-entity-type="node" data-entity-uuid="1aacc7ad-c5fe-47b0-a23c-2168a16d629f" data-entity-substitution="canonical" title="CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntarily Bring Under Veterinary Oversight All Products That Continue to be Available Over-the-Counter ">CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntarily Bring Under Veterinary Oversight All Products That Continue to be Available Over-the-Counter</a><br>June 11, 2021</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-264-standardized-medicated-feed-assay-limits" data-entity-type="node" data-entity-uuid="f8a77314-ad5c-430f-9192-1a048ad04ccd" data-entity-substitution="canonical" title="CVM GFI #264 Standardized Medicated Feed Assay Limits">CVM GFI #264 Standardized Medicated Feed Assay Limits</a><br>February 27, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-265-use-data-foreign-investigational-studies-support-effectiveness-new-animal-drugs" data-entity-type="node" data-entity-uuid="06d4dc4b-e328-4394-ae32-a58b42f4a3df" data-entity-substitution="canonical" title="CVM GFI #265 Use of Data from Foreign Investigational Studies to Support Effectiveness of New Animal Drugs">CVM GFI #265 Use of Data from Foreign Investigational Studies to Support Effectiveness of New Animal Drugs</a><br>October 6, 2021</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-266-use-real-world-data-and-real-world-evidence-support-effectiveness-new-animal-drugs" data-entity-type="node" data-entity-uuid="d3cb23da-67a0-4ec1-867c-60009b4d1299" data-entity-substitution="canonical" title="CVM GFI #266 Use of Real-World Data and Real-World Evidence to Support Effectiveness of New Animal Drugs">CVM GFI #266 Use of Real-World Data and Real-World Evidence to Support Effectiveness of New Animal Drugs</a><br>October 6, 2021</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-267-biomarkers-and-surrogate-endpoints-clinical-studies-support-effectiveness-new-animal" data-entity-type="node" data-entity-uuid="9294f38f-e1b5-4bee-9da6-947146072a26" data-entity-substitution="canonical" title="CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs">CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs</a><br>October 6, 2021</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-268-adaptive-and-other-innovative-designs-effectiveness-studies-new-animal-drugs" data-entity-type="node" data-entity-uuid="61d92ab3-7ac4-481a-b27c-93a3afe0fc7b" data-entity-substitution="canonical" title="CVM GFI #268 Adaptive and Other Innovative Designs for Effectiveness Studies of New Animal Drugs">CVM GFI #268 Adaptive and Other Innovative Designs for Effectiveness Studies of New Animal Drugs</a><br>October 6, 2021</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-271-reporting-and-mitigating-animal-drug-shortages" data-entity-type="node" data-entity-uuid="7b0f445c-0e6a-43b6-bc07-7826c896e954" data-entity-substitution="canonical" title="CVM GFI #271 Reporting and Mitigating Animal Drug Shortages">CVM GFI #271 Reporting and Mitigating Animal Drug Shortages</a><br>May 12, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-272-practices-prevent-unsafe-contamination-animal-feed-drug-carryover" data-entity-type="node" data-entity-uuid="a6b80e8c-f8e2-4255-8483-2bfc4541fe83" data-entity-substitution="canonical" title="CVM GFI #272 Practices to Prevent Unsafe Contamination of Animal Feed from Drug Carryover">CVM GFI #272 Practices to Prevent Unsafe Contamination of Animal Feed from Drug Carryover</a><br>January 30, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-273-defining-durations-use-approved-medically-important-antimicrobial-drugs-fed-food" data-entity-type="node" data-entity-uuid="64ba0c50-58ae-402c-a14f-36b87b5306ac" data-entity-substitution="canonical" title="CVM GFI #273 Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals">CVM GFI #273 Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals</a><br>September 26, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-276-effectiveness-anthelmintics-specific-recommendations-products-proposed-prevention" data-entity-type="node" data-entity-uuid="7190e2ed-1a1b-4905-bb05-a94f8a8a369d" data-entity-substitution="canonical" title="CVM GFI #276 Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs">CVM GFI #276 Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs</a><br>June 26, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-278-human-user-safety-new-and-abbreviated-new-animal-drug-applications" data-entity-type="node" data-entity-uuid="c93dedb0-dd54-43dc-8b01-95c504f0568d" data-entity-substitution="canonical" title="CVM GFI #278 Human User Safety in New and Abbreviated New Animal Drug Applications">CVM GFI #278 Human User Safety in New and Abbreviated New Animal Drug Applications</a><br>June 21, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-279-demonstrating-bioequivalence-type-medicated-articles-containing-active-pharmaceutical" data-entity-type="node" data-entity-uuid="264431d8-40dd-46b4-964b-1d14e0810722" data-entity-substitution="canonical" title="CVM GFI #279 Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered to be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting">CVM GFI #279 Demonstrating Bioequivalence for Type A Medicated Articles Containing Active Pharmaceutical Ingredient(s) Considered to be Poorly Soluble in Aqueous Media, That Exhibit Little to No Systemic Bioavailability, and Are Locally Acting</a><br>June 21, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-281-infectious-otitis-externa-drugs-topical-use-dogs" data-entity-type="node" data-entity-uuid="b6af8d68-0421-47cc-9ec9-43b5c85af651" data-entity-substitution="canonical" title="CVM GFI #281 Infectious Otitis Externa Drugs for Topical Use in Dogs">CVM GFI #281 Infectious Otitis Externa Drugs for Topical Use in Dogs</a><br>March 31, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-282-informed-consent-forms-studies-enroll-client-owned-companion-animals" data-entity-type="node" data-entity-uuid="612febd6-c4b9-4ea9-91c9-85b0f42fa2ba" data-entity-substitution="canonical" title="CVM GFI #282 Informed Consent Forms for Studies that Enroll Client-Owned Companion Animals">CVM GFI #282 Informed Consent Forms for Studies that Enroll Client-Owned Companion Animals</a><br>September 15, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-283-priority-zoonotic-animal-drug-designation-and-review-process" data-entity-type="node" data-entity-uuid="ef7956de-e2d3-43ae-afb1-71d9e77945a4" data-entity-substitution="canonical" title="CVM GFI #283 Priority Zoonotic Animal Drug Designation and Review Process">CVM GFI #283 Priority Zoonotic Animal Drug Designation and Review Process</a><br>June 26, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-284-using-relative-supersaturation-support-urinary-tract-health-claims-adult-maintenance-cat" data-entity-type="node" data-entity-uuid="ec649795-9347-4db7-8e88-6fd8be28c2b7" data-entity-substitution="canonical" title="CVM GFI #284 Using Relative Supersaturation to Support “Urinary Tract Health” Claims for Adult Maintenance Cat Food">CVM GFI #284 Using Relative Supersaturation to Support “Urinary Tract Health” Claims for Adult Maintenance Cat Food</a><br>October 15, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-285-manufacture-batches-support-original-nadas-anadas-and-cnadas" data-entity-type="node" data-entity-uuid="3655ec28-2ac2-4678-8356-41d002c42767" data-entity-substitution="canonical" title="CVM GFI #285 - Manufacture of Batches in Support of Original NADAs, ANADAs, and CNADAs">CVM GFI #285 - Manufacture of Batches in Support of Original NADAs, ANADAs, and CNADAs</a><br>March 18, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-286-vich-gl60-good-manufacturing-practice-active-pharmaceutical-ingredients-used-veterinary" data-entity-type="node" data-entity-uuid="8fe3cc32-099f-4cce-b0c8-975029f1a746" data-entity-substitution="canonical" title="CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products">CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products</a><br>January 25, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-287-raw-data-safety-and-effectiveness-studies" data-entity-type="node" data-entity-uuid="c93a44ee-443a-4718-92c2-a6140d0332d8" data-entity-substitution="canonical" title="CVM GFI #287 - Raw Data for Safety and Effectiveness Studies">CVM GFI #287 - Raw Data for Safety and Effectiveness Studies</a><br>April 29, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-288-chemistry-manufacturing-and-controls-support-recombinant-protein-products-veterinary" data-entity-type="node" data-entity-uuid="f0060461-9837-414a-a632-cc0fa25bfab9" data-entity-substitution="canonical" title="CVM GFI #288 Chemistry, Manufacturing, and Controls in Support of Recombinant Protein Products for Veterinary Medicinal Use">CVM GFI #288 Chemistry, Manufacturing, and Controls in Support of Recombinant Protein Products for Veterinary Medicinal Use</a><br>June 24, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-290-vich-gl61-pharmaceutical-development" data-entity-type="node" data-entity-uuid="109fb3e4-ad13-41b1-a02a-ff2ac0e0e190" data-entity-substitution="canonical" title="CVM GFI #290 (VICH GL61) – Pharmaceutical Development">CVM GFI #290 (VICH GL61) – Pharmaceutical Development</a><br>May 6, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-292-chemistry-manufacturing-and-controls-considerations-type-medicated-articles" data-entity-type="node" data-entity-uuid="7846cd9a-63ac-4bf5-ab38-c7299650ce64" data-entity-substitution="canonical" title="CVM GFI #292 Chemistry, Manufacturing, and Controls Considerations for Type A Medicated Articles">CVM GFI #292 Chemistry, Manufacturing, and Controls Considerations for Type A Medicated Articles</a><br>June 24, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-293-fda-enforcement-policy-aafco-defined-animal-feed-ingredients" data-entity-type="node" data-entity-uuid="aa9fe5bb-ff77-43ad-b390-7dfa9123ebe2" data-entity-substitution="canonical" title="CVM GFI #293 - FDA Enforcement Policy for AAFCO-Defined Animal Feed Ingredients">CVM GFI #293 - FDA Enforcement Policy for AAFCO-Defined Animal Feed Ingredients</a><br>October 24, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/cvm-gfi-294-animal-food-ingredient-consultation-afic" data-entity-type="node" data-entity-uuid="c8f1c74d-87d4-455a-9528-1b1a9d032b36" data-entity-substitution="canonical" title="CVM GFI #294 - Animal Food Ingredient Consultation (AFIC)">CVM GFI #294 - Animal Food Ingredient Consultation (AFIC)</a><br>January 7, 2025</li></ul><h2 id="cross">Cross-Cutting Guidances</h2><ul><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-and-fda-advisory-levels-deoxynivalenol-don-finished-wheat-products-human" data-entity-type="node" data-entity-uuid="35e00eb1-da40-4cae-955c-597c73dfed31" data-entity-substitution="canonical" title="Guidance for Industry and FDA: Advisory Levels for Deoxynivalenol (DON) in Finished Wheat Products for Human Consumption and Grains and Grain By-Products used for Animal Feed">Guidance for Industry and FDA: Advisory Levels for Deoxynivalenol (DON) in Finished Wheat Products for Human Consumption and Grains and Grain By-Products used for Animal Feed </a><br>June 29, 2010</li><li><a href="/regulatory-information/search-fda-guidance-documents/brief-summary-and-adequate-directions-use-disclosing-risk-information-consumer-directed-print" data-entity-type="node" data-entity-uuid="542a16e2-b8c8-46bd-a940-f40a76218b2e" data-entity-substitution="canonical" title="Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs">Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs</a><br>August 5, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/communications-firms-health-care-providers-regarding-scientific-information-unapproved-uses" data-entity-type="node" data-entity-uuid="8029f4f5-2cbb-4682-aedb-34f49dcf099e" data-entity-substitution="canonical" title="Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers">Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers</a><br>October 24, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/conducting-remote-regulatory-assessments-questions-and-answers" data-entity-type="node" data-entity-uuid="2a062c46-b080-4148-9b2c-1e531b727a01" data-entity-substitution="canonical" title="Conducting Remote Regulatory Assessments Questions and Answers">Conducting Remote Regulatory Assessments Questions and Answers</a><br>January 26, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/data-integrity-and-compliance-drug-cgmp-questions-and-answers" data-entity-type="node" data-entity-uuid="c5e27bc1-d1d9-4dfa-8881-a11e7b58a466" data-entity-substitution="canonical" title="Data Integrity and Compliance With Drug CGMP: Questions and Answers">Data Integrity and Compliance With Drug CGMP Questions and Answers Guidance for Industry</a><br>April 14, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/draft-guidance-industry-describing-hazard-needs-control-documents-accompanying-food-required-four" data-entity-type="node" data-entity-uuid="3c3e6004-157e-48b8-a536-da1850d5d068" data-entity-substitution="canonical" title="Draft Guidance for Industry: Describing a Hazard That Needs Control in Documents Accompanying the Food, as Required by Four Rules Implementing FSMA">Draft Guidance for Industry: Describing a Hazard That Needs Control in Documents Accompanying the Food, as Required by Four Rules Implementing FSMA </a><br>November 1, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/distributing-scientific-and-medical-publications-risk-information-approved-prescription-drugs-and" data-entity-type="node" data-entity-uuid="511b2586-acfd-4863-b7e2-17947bb31592" data-entity-substitution="canonical" title="Distributing Scientific and Medical Publications on Risk Information for Approved Prescription Drugs and Biological Products—Recommended Practices">Distributing Scientific and Medical Publications on Risk Information for Approved Prescription Drugs and Biological Products—Recommended Practices</a><br>June 6, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/electronic-systems-electronic-records-and-electronic-signatures-clinical-investigations-questions" data-entity-type="node" data-entity-uuid="6e699c2f-84d4-4af1-ac3f-74d2f8de1189" data-entity-substitution="canonical" title="Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers">Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers</a><br>October 2, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-exports-under-fda-export-reform-and-enhancement-act-1996" data-entity-type="node" data-entity-uuid="082c66b6-1b92-40fb-a39e-a93d882cc2a7" data-entity-substitution="canonical" title=" Guidance for Industry: Exports Under the FDA Export Reform and Enhancement Act of 1996 ">Guidance for Industry: Exports Under the FDA Export Reform and Enhancement Act of 1996</a><br>July 23, 2007</li><li><a href="/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-registration-food-facilities" data-entity-type="node" data-entity-uuid="23401a40-b46d-42a5-8bab-a70524963ef6" data-entity-substitution="canonical" title="Small Entity Compliance Guide: Registration of Food Facilities">Small Entity Compliance Guide: Registration of Food Facilities</a><br>May 29, 2018</li><li><a href="/regulatory-information/search-fda-guidance-documents/draft-guidance-industry-questions-and-answers-regarding-reportable-food-registry-established-food" data-entity-type="node" data-entity-uuid="d98fb765-16ae-45ad-aee5-f9d1ae28ce0c" data-entity-substitution="canonical" title="Draft Guidance for Industry: Questions and Answers Regarding the Reportable Food Registry as Established by the Food and Drug Administration Amendments Act of 2007 (Edition 2)">Draft Guidance for Industry: Questions and Answers Regarding the Reportable Food Registry as Established by the Food and Drug Administration Amendments Act of 2007 (Edition 2)</a><br>May 24, 2010</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-questions-and-answers-regarding-food-facility-registration-seventh-edition" data-entity-type="node" data-entity-uuid="403cd782-b9b9-4f99-b752-09579292104b" data-entity-substitution="canonical" title="Guidance for Industry: Questions and Answers Regarding Food Facility Registration (Seventh Edition)">Guidance for Industry: Questions and Answers Regarding Food Facility Registration (Seventh Edition) </a><br>August 1, 2018</li><li><a href="/regulatory-information/search-fda-guidance-documents/formal-dispute-resolution-scientific-and-technical-issues-related-pharmaceutical-cgmp" data-entity-type="node" data-entity-uuid="43714edf-8b04-454e-b3d6-9216d52c9e34" data-entity-substitution="canonical" title="Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP">Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP_PRA</a><br>January 11, 2006</li><li><a href="/regulatory-information/search-fda-guidance-documents/fulfilling-regulatory-requirements-postmarketing-submissions-interactive-promotional-media" data-entity-type="node" data-entity-uuid="0966beff-cb42-4a9d-bb66-a9c7be9b4037" data-entity-substitution="canonical" title="Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics">Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics</a><br>January 13, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-frequently-asked-questions-about-gras-substances-intended-use-human-or-animal-food" data-entity-type="node" data-entity-uuid="7c75bcdf-31d7-42b2-95ee-0f9a50f84c32" data-entity-substitution="canonical" title="Guidance for Industry: Frequently Asked Questions About GRAS for Substances Intended for Use in Human or Animal Food">Guidance for Industry: Frequently Asked Questions About GRAS for Substances Intended for Use in Human or Animal Food</a><br>October 1, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-best-practices-convening-gras-panel" data-entity-type="node" data-entity-uuid="c5858db5-c3b4-4553-bb22-e3c0871b3814" data-entity-substitution="canonical" title="Guidance for Industry: Best Practices for Convening a GRAS Panel">Draft Guidance for Industry: Best Practices for Convening a GRAS Panel</a><br>November 1, 2017</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-regulatory-framework-substances-intended-use-human-food-or-animal-food-basis" data-entity-type="node" data-entity-uuid="dd944f75-06c2-411c-8e49-856df1d37ce7" data-entity-substitution="canonical" title="Guidance for Industry: Regulatory Framework for Substances Intended for Use in Human Food or Animal Food on the Basis of the Generally Recognized as Safe (GRAS) Provision of the Federal Food, Drug, and Cosmetic Act">Guidance for Industry: Regulatory Framework for Substances Intended for Use in Human Food or Animal Food on the Basis of the Generally Recognized as Safe (GRAS) Provision of the Federal Food, Drug, and Cosmetic Act </a><br>November 1, 2017</li><li><a href="/regulatory-information/search-fda-guidance-documents/harmonizing-compendial-standards-drug-application-approval-using-usp-pending-monograph-process" data-entity-type="node" data-entity-uuid="00ecd7ff-7547-49d7-9a84-9cd56fde1e11" data-entity-substitution="canonical" title="Harmonizing Compendial Standards With Drug Application Approval Using the USP Pending Monograph Process Guidance for Industry ">Harmonizing Compendial Standards With Drug Application Approval Using the USP Pending Monograph Process Guidance for Industry</a><br>July 10, 2019</li><li><a href="/regulatory-information/search-fda-guidance-documents/initiation-voluntary-recalls-under-21-cfr-part-7-subpart-c" data-entity-type="node" data-entity-uuid="bb8b6fd5-f847-479d-921d-91f0ebde582b" data-entity-substitution="canonical" title="Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C">Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C Guidance for Industry and FDA Staff</a><br>March 4, 2022</li><li><a href="/regulatory-information/search-fda-guidance-documents/internetsocial-media-platforms-character-space-limitations-presenting-risk-and-benefit-information-0" data-entity-type="node" data-entity-uuid="e9cfcab7-66fc-46cb-95af-86e02394eb1d" data-entity-substitution="canonical" title="Internet/Social Media Platforms with Character Space Limitations— Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices">Internet/Social Media Platforms with Character Space Limitations— Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices</a><br>June 17, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/addressing-misinformation-about-medical-devices-and-prescription-drugs-questions-and-answers" data-entity-type="node" data-entity-uuid="08fd13d6-3de5-40b7-b8de-b7302d0ae8e0" data-entity-substitution="canonical" title="Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers">Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices</a><br>June 17, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-necessity-use-food-product-categories-food-facility-registrations-and-updates-food" data-entity-type="node" data-entity-uuid="ada1949f-8ae1-4f59-b869-fb35d1c16e86" data-entity-substitution="canonical" title="Guidance for Industry: Necessity of the Use of Food Product Categories in Food Facility Registrations and Updates to Food Product Categories (2016 Edition)">Guidance for Industry: Necessity of the Use of Food Product Categories in Food Facility Registrations and Updates to Food Product Categories (2016 Edition)</a><br>September 1, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance" data-entity-type="node" data-entity-uuid="d8a82b4f-66e5-42e7-9af1-0f6d50a02350" data-entity-substitution="canonical" title="PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance">PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance</a><br>September 29, 2004</li><li><a href="/regulatory-information/search-fda-guidance-documents/pharmaceutical-components-risk-melamine-contamination" data-entity-type="node" data-entity-uuid="c590a9d9-7d3e-42ed-8132-7e43da49da21" data-entity-substitution="canonical" title="Pharmaceutical Components at Risk for Melamine Contamination">Pharmaceutical Components at Risk for Melamine Contamination</a><br>August 6, 2009</li><li><a href="/regulatory-information/search-fda-guidance-documents/policy-testing-alcohol-ethanol-and-isopropyl-alcohol-methanol" data-entity-type="node" data-entity-uuid="0c1cb576-6373-470a-9cb3-a0e2d029ebec" data-entity-substitution="canonical" title="Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol">Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol, Including During the Public Health Emergency (COVID-19)</a><br>January 19, 2021</li><li><a href="/regulatory-information/search-fda-guidance-documents/postapproval-changes-drug-substances-guidance-industry" data-entity-type="node" data-entity-uuid="b6c4d1e0-b7f2-407a-b10c-c8ec73fbb627" data-entity-substitution="canonical" title="Postapproval Changes to Drug Substances Guidance for Industry">Postapproval Changes to Drug Substances Guidance for Industry</a><br>September 11, 2018</li><li><a href="/regulatory-information/search-fda-guidance-documents/presenting-quantitative-efficacy-and-risk-information-direct-consumer-dtc-promotional-labeling-and" data-entity-type="node" data-entity-uuid="c1b4f47d-89ea-47fb-9a3c-baa6b55a8bb4" data-entity-substitution="canonical" title="Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional Labeling and Advertisements">Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DTC) Promotional Labeling and Advertisements</a><br>June 27, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/presenting-risk-information-prescription-drug-and-medical-device-promotion" data-entity-type="node" data-entity-uuid="0a4beeac-f908-4271-8a19-6f4f6c6b67fe" data-entity-substitution="canonical" title="Presenting Risk Information in Prescription Drug and Medical Device Promotion">Presenting Risk Information in Prescription Drug and Medical Device Promotion</a><br>May 27, 2009</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-prior-notice-imported-food-questions-and-answers-edition-4" data-entity-type="node" data-entity-uuid="9abb7864-6fbc-4071-9416-99cf704301cd" data-entity-substitution="canonical" title="Guidance for Industry: Prior Notice of Imported Food Questions and Answers (Edition 4)">Guidance for Industry: Prior Notice of Imported Food Questions and Answers (Edition 3) </a><br>June 1, 2016</li><li><a href="/regulatory-information/search-fda-guidance-documents/product-name-placement-size-and-prominence-advertising-and-promotional-labeling-final" data-entity-type="node" data-entity-uuid="4a787344-9ce8-43d4-8e7e-2c6e78b429f0" data-entity-substitution="canonical" title="Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final">Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling</a><br>December 11, 2017</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-fda-records-access-authority-under-sections-414-and-704-federal-food-drug-cosmetic" data-entity-type="node" data-entity-uuid="8cf91adc-72a1-498d-b339-2bcb66539686" data-entity-substitution="canonical" title="Guidance for Industry: FDA Records Access Authority Under Sections 414 and 704 of the Federal Food, Drug, & Cosmetic Act">Guidance for Industry: FDA Records Access Authority Under Sections 414 and 704 of the Federal Food, Drug, & Cosmetic Act</a><br>April 4, 2014</li><li><a href="/regulatory-information/search-fda-guidance-documents/providing-regulatory-submissions-electronic-format-drug-establishment-registration-and-drug-listing" data-entity-type="node" data-entity-uuid="507cb9b7-8d10-4ab0-9176-74bbd8eb98b1" data-entity-substitution="canonical" title="Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing">Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing</a><br>May 28, 2009</li><li><a href="/regulatory-information/search-fda-guidance-documents/public-availability-lists-retail-consignees-effectuate-certain-human-and-animal-food-recalls" data-entity-type="node" data-entity-uuid="668c091b-6926-4046-9ddb-1972804fb483" data-entity-substitution="canonical" title="Public Availability of Lists of Retail Consignees to Effectuate Certain Human and Animal Food Recalls">Public Availability of Lists of Retail Consignees to Effectuate Certain Human and Animal Food Recalls</a><br>November 23, 2020</li><li><a href="/regulatory-information/search-fda-guidance-documents/public-warning-notification-recalls-under-21-cfr-part-7-subpart-c" data-entity-type="node" data-entity-uuid="40fac53e-c829-470a-b31e-295b9f0a6b95" data-entity-substitution="canonical" title="Public Warning-Notification of Recalls Under 21 CFR Part 7, Subpart C ">Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart C</a><br>February 8, 2019</li><li><a href="/regulatory-information/search-fda-guidance-documents/remote-interactive-evaluations-drug-manufacturing-and-bioresearch-monitoring-facilities" data-entity-type="node" data-entity-uuid="e3b0dbec-48b0-435d-a68b-caad035739d9" data-entity-substitution="canonical" title="Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities">Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities</a><br>October 26, 2023</li><li><a href="/regulatory-information/search-fda-guidance-documents/reporting-amount-listed-drugs-and-biological-products-technical-conformance-guide" data-entity-type="node" data-entity-uuid="178671ae-2d24-4679-ad4e-b66b55a1abf9" data-entity-substitution="canonical" title="Reporting Amount of Listed Drugs and Biological Products Technical Conformance Guide">Reporting Amount of Listed Drugs and Biological Products Technical Conformance Guide</a><br>October 29, 2021</li><li><a href="/regulatory-information/search-fda-guidance-documents/reporting-amount-listed-drugs-and-biological-products-under-section-510j3-fdc-act" data-entity-type="node" data-entity-uuid="438f2199-9741-4c7f-a40d-7939794a727e" data-entity-substitution="canonical" title="Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act">Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act</a><br>February 6, 2024</li><li><a href="/regulatory-information/search-fda-guidance-documents/responding-unsolicited-requests-label-information-about-prescription-drugs-and-medical-devices" data-entity-type="node" data-entity-uuid="24b63182-6df4-41a0-b314-19971d1a5bbd" data-entity-substitution="canonical" title="Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices">Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices</a><br>December 27, 2011</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-sanitary-transportation-food" data-entity-type="node" data-entity-uuid="31bf3cc0-b721-4c0a-9ab7-362106f2d622" data-entity-substitution="canonical" title="Guidance for Industry: Sanitary Transportation of Food">Guidance for Industry: Sanitary Transportation of Food</a><br>April 30, 2010</li><li><a href="/regulatory-information/search-fda-guidance-documents/submission-documentation-applications-parametric-release-human-and-veterinary-drug-products" data-entity-type="node" data-entity-uuid="50952734-c0eb-4203-8a6b-701b6047cdac" data-entity-substitution="canonical" title="Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes">Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes</a><br>February 25, 2010</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-testing-salmonella-species-human-foods-and-direct-human-contact-animal-foods" data-entity-type="node" data-entity-uuid="89424745-baf2-40ac-a6da-8a02df6a63b6" data-entity-substitution="canonical" title="Guidance for Industry: Testing for Salmonella Species in Human Foods and Direct-Human-Contact Animal Foods">Guidance for Industry: Testing for Salmonella Species in Human Foods and Direct-Human-Contact Animal Foods</a><br>March 1, 2012</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-voluntary-labeling-indicating-whether-foods-have-or-have-not-been-derived" data-entity-type="node" data-entity-uuid="b19cf664-c654-45b9-b8f8-18039f9bb5b6" data-entity-substitution="canonical" title="Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or Have Not Been Derived from Genetically Engineered Plants">Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or Have Not Been Derived from Genetically Engineered Plants</a><br>January 19, 2001</li><li><a href="/regulatory-information/search-fda-guidance-documents/guidance-industry-fdas-voluntary-qualified-importer-program" data-entity-type="node" data-entity-uuid="395b0974-de62-488a-9ae5-73f53245948e" data-entity-substitution="canonical" title="Guidance for Industry: FDA's Voluntary Qualified Importer Program">Guidance for Industry: FDA's Voluntary Qualified Importer Program</a><br>June 3, 2015</li><li><a href="/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-what-you-need-know-about-establishment-and-maintenance-records" data-entity-type="node" data-entity-uuid="f2ca56e2-2f00-4353-9685-eff471b06d9f" data-entity-substitution="canonical" title="Small Entity Compliance Guide: What You Need to Know About Establishment and Maintenance of Records">Guidance for Industry: What You Need to Know About Establishment and Maintenance of Records; Small Entity Compliance Guide</a><br>April 4, 2014 </li></ul>   </div> <aside class="col-md-2 col-md-push-2" role="complementary"> <section id="block-entityviewcontent-4" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="region region-"> <aside class="lcds-card lcds-card--border-top"> <ul role="menu" class="lcds-description-list"> <li role="menuitem" class="node-current-date lcds-description-list__item"> <div> <h2 class="lcds-description-list__item-heading">Content current as of:</h2> <p class="lcds-description-list__item-text"><time datetime="2025-01-06T00:00:00Z">01/06/2025</time> </p> </div> </li> <li role="menuitem" class="lcds-description-list__item"> <div> </div> </li> </ul> </aside> </div> </section> </aside> <aside class="col-md-2 col-md-pull-10" role="complementary"> <section id="block-entityviewcontent-3" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> <div class="region region-"> <nav id="section-nav"class="lcds-card lcds-section-nav lcds-section-nav--side hidden-xs hidden-sm"> <ul class="lcds-section-nav__list lcds-section-nav--side__list"> <li> <a href="/animal-veterinary/guidance-regulations/guidance-industry" class="lcds-section-nav__link lcds-section-nav--side__link lcds-section-nav__parent-link lcds-section-nav--side__parent-link"> Guidance for Industry </a> <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_4 js-view-dom-id-c3ef9d73e017413c542fb7d85a88d138c028005412592fa9f62ef8af404d0036"> <div class="item-list"> <ul class="lcds-section-nav__active lcds-section-nav__list lcds-section-nav--side__list"> <li><a href="/animal-veterinary/guidance-industry/guidance-number" class="lcds-section-nav__link lcds-section-nav--side__link">Guidance by Number</a></li> <li><a href="/animal-veterinary/guidance-industry/guidances-under-development" class="lcds-section-nav__link lcds-section-nav--side__link">Guidances Under Development</a></li> <li><a href="/animal-veterinary/guidance-industry/newly-added-guidances" class="lcds-section-nav__link lcds-section-nav--side__link">Newly Added Guidances</a></li> <li><a href="/animal-veterinary/guidance-industry/withdrawnreplaced-guidances" class="lcds-section-nav__link lcds-section-nav--side__link">Withdrawn/Replaced Guidances</a></li> </ul> </div> </div> </div> <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_1 js-view-dom-id-92c8229a3c0b26cd9f03f52d2f5d791b19b5432f1bd9107ba571fdd4ba758b39"> </div> </div> </li> </ul> </nav> </div> </section> </aside> </article> </main> </div> </div> <div class="region region-subscribe"> <section id="block-entityviewcontent-5" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix"> </section> </div> <footer class="lcds-footer container-fluid"> <div class="row lcds-footer__primary"> <h2 id="footer-heading" class="sr-only">Footer Links</h2> <nav class="text-center"> <div class="col-sm-4"> <ul class="nav"> <li><a href="/about-fda/about-website/fdagov-archive" >FDA Archive</a></li> <li><a href="/about-fda" >About FDA</a></li> <li><a href="/about-fda/about-website/internet-accessibility" >Accessibility</a></li> </ul> </div> <div class="col-sm-4"> <ul class="nav"> <li><a href="/about-fda/visitor-information" >Visitor Information</a> </li> <li><a href="/about-fda/about-website/website-policies" >Website Policies / Privacy</a></li> <li><a href="/about-fda/jobs-and-training-fda/no-fear-act" >No FEAR Act</a></li> <li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" >Vulnerability Disclosure Policy</a></li> </ul> </div> <div class="col-sm-4"> <ul class="nav"> <li><a href="/regulatory-information/freedom-information" title="Freedom of Information Act">FOIA</a></li> <li><a href="https://www.hhs.gov/" title="Health and Human Services" target="_blank">HHS.gov</a></li> <li><a href="https://www.usa.gov/" target="_blank">USA.gov</a></li> </ul> </div> </nav> </div> <div class="row lcds-footer__secondary"> <div class="col-sm-12 col-md-6 col-lg-4 lcds-footer__social-links"> <a href="/about-fda/contact-fda" class="btn btn-default btn-md">Contact FDA</a> <a href="https://www.facebook.com/FDA" title="Follow FDA on Facebook" class="no-disclaimer"> <span class="fa fa-facebook fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on Facebook</span> </span> </a> <a href="https://x.com/US_FDA" title="Follow FDA on X" class="no-disclaimer"> <svg class="icon-svg-inline fa-2x" aria-hidden="true"> <use href="/themes/custom/preview/assets/images/fa-icons.svg#icon-x-twitter"> </svg> <span class="sr-only">Follow FDA on X</span> </a> <a href="https://instagram.com/FDA" title="Follow FDA on Instagram" class="no-disclaimer"> <span class="fa fa-instagram fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on Instagram</span> </span> </a> <br class='visible-xs-inline'/> <a href="https://www.linkedin.com/company/fda/" title="Follow FDA on LinkedIn" class="no-disclaimer"> <span class="fa fa-linkedin fa-2x" aria-hidden="true"> <span class="sr-only">Follow FDA on LinkedIn</span> </span> </a> <a href="https://youtube.com/@US_FDA" title="View FDA videos on YouTube" class="no-disclaimer"> <span class="fa fa-youtube fa-2x" aria-hidden="true"> <span class="sr-only">View FDA videos on YouTube</span> </span> </a> <a href="/about-fda/contact-fda/subscribe-podcasts-and-news-feeds" title="Subscribe to FDA RSS feeds"> <span class="fa fa-rss fa-2x" aria-hidden="true"> <span class="sr-only">Subscribe to FDA RSS feeds</span> </span> </a> </div> <a href="/" title="FDA Homepage"> <div class="visible-lg-block col-lg-4 text-center lcds-footer__logo"> <span class="sr-only">FDA Homepage</span> </div> </a> <div class="col-sm-12 col-md-6 col-lg-4 text-center lcds-footer__contact-number"> <span class="fa fa-phone" aria-hidden="true"> </span> <span class="sr-only">Contact Number</span> 1-888-INFO-FDA (1-888-463-6332) </div> </div>  </footer> <a href="" id="btn-top" class="btn btn-primary btn-top"><span class="sr-only">Back to </span>Top</a> </div> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/354162","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"fda_ckeditor_enhancements":{"basePath":"modules\/custom\/fda_ckeditor_enhancements"},"google_analytics":{"account":"G-273DTKB5QW","trackOutbound":true,"trackMailto":true,"trackTel":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"bootstrap":{"forms_has_error_value_toggle":1,"modal_animation":1,"modal_backdrop":"true","modal_focus_input":1,"modal_keyboard":1,"modal_select_text":1,"modal_show":1,"modal_size":"","popover_enabled":1,"popover_animation":1,"popover_auto_close":1,"popover_container":"body","popover_content":"","popover_delay":"0","popover_html":0,"popover_placement":"right","popover_selector":"","popover_title":"","popover_trigger":"click"},"ajax":[],"user":{"uid":0,"permissionsHash":"3aef67b4ac7d861d8624bf1f7ab2bc9cfc56d3c25b7d709dc15466dfa996dfb0"}}</script> <script src="/files/js/js_KwaVrVDnb9vBN4UOzg4J4320oQW-EMMozpPhvFZziRU.js?scope=footer&delta=0&language=en&theme=preview&include=eJxlj1GOwjAMRC8UyP6sxG0i1zEhIslEsRdUTg8FUSr2xxqPpZlnPkvMhhFyi9JsKuCz32h3RDO6iqKK3-i9S0AqEqhRmS2z-m_D6awm1U-k4vqQS5arTwUTlZ3aXHJL_2weuZu6CTC1Qd13dFxkuGOkwG9WaSdqLPUBqZ6YMWJGC4a0AOgJwxhR3BKt_jn3FfGvyCsHtZe8JLxu4ffnsDEfL8MaTNSvagXlQbdZ0oc8Un92vfe1fbeC3QF5KozJ"></script> <script type="text/javascript" src="/z4AWJAR8FMJAZ0Gr8yxw/N9Q3czz0N2Jrp9ma/HRNLRk0/JG/ooezF2J3gB"></script></body> </html>